The Healthcare sector includes companies that provide medical services, manufacture medical equipment and drugs, and develop biotechnologies and healthcare solutions. This sector spans a wide range of industries, from pharmaceutical companies and biotechnology firms to healthcare providers, hospitals, and medical device manufacturers. The healthcare sector is considered defensive, as demand for medical care remains constant regardless of the economic environment. Examples include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Sector Read
Coverage Overview
A quick read on breadth, benchmark scope, and data participation.
Median pillar scores with the sector middle band for a quick read on quality, resilience, and valuation posture. Based on 2025.
Growth
Sample 325
Profitability
Sample 325
Health
Sample 325
Efficiency
Sample 325
Valuation
Sample 321
Distribution bands and center points across 1266 contributing companies. Use the tooltip for quartiles, completeness, and freshness, then compare those norms against the leaderboard cards below.
Trend highlights are prioritised around Cash Runway, Operating Margin for this sector.
Latest composite and moat snapshots, plus two sector-relevant benchmark metrics chosen for Healthcare. Tracking Cash Runway and Operating Margin.
Scan scale, positioning, and latest annual metric momentum across the sector without leaving the benchmark view.
| Company | Market Cap | Positioning |
Cash Runway
Latest annual + YoY
|
Operating Margin
Latest annual + YoY
|
|---|---|---|---|---|
|
929.55B
|
Composite
47.6
Moat
47.9
|
-
No YoY
|
5.1%
-33.8
YoY
|
|
|
535.63B
|
Composite
61.1
Moat
80.6
|
-
No YoY
|
27.2%
+2.2
YoY
|
|
|
ABBV
AbbVie Inc.
|
358.43B
|
Composite
53.1
Moat
-
|
-
No YoY
|
34.7%
+13.6
YoY
|
|
333.54B
|
Composite
56.4
Moat
-
|
-
No YoY
|
4.2%
-3.8
YoY
|
|
|
AZN
Astrazeneca PLC
|
282.72B
|
Composite
57.5
Moat
-
|
-
No YoY
|
23.4%
+4.9
YoY
|
|
NVS
Novartis AG
|
277.42B
|
Composite
60.1
Moat
-
|
-
No YoY
|
31.1%
+3.0
YoY
|
|
277.36B
|
Composite
60.2
Moat
78.1
|
-
No YoY
|
41.2%
+9.7
YoY
|
|
|
NVO
Novo Nordisk A/S
|
204.32B
|
Composite
59.3
Moat
81.4
|
-
No YoY
|
41.3%
-2.9
YoY
|
|
AMGN
Amgen Inc.
|
177.61B
|
Composite
61.0
Moat
-
|
-
No YoY
|
24.7%
+3.0
YoY
|
|
176.32B
|
Composite
60.8
Moat
-
|
-
No YoY
|
18.2%
+0.2
YoY
|
|
|
166.44B
|
Composite
61.7
Moat
-
|
-
No YoY
|
40.1%
+3.6
YoY
|
|
|
160.61B
|
Composite
68.2
Moat
-
|
-
No YoY
|
29.3%
+1.2
YoY
|
|
|
151.56B
|
Composite
68.5
Moat
75.0
|
-
No YoY
|
18.2%
+1.9
YoY
|
|
|
PFE
Pfizer, Inc.
|
150.92B
|
Composite
44.4
Moat
-
|
-
No YoY
|
24.7%
+1.4
YoY
|
|
124.33B
|
Composite
64.1
Moat
-
|
-
No YoY
|
20.9%
+0.5
YoY
|
|
|
114.87B
|
Composite
55.1
Moat
-
|
-
No YoY
|
28.5%
+16.3
YoY
|
|
|
112.60B
|
Composite
68.4
Moat
-
|
-
No YoY
|
20.1%
-0.5
YoY
|
|
|
111.47B
|
Composite
49.7
Moat
-
|
-
No YoY
|
2.6%
+0.3
YoY
|
|
|
108.54B
|
Composite
71.6
Moat
-
|
149.0
No YoY
|
38.0%
+40.1
YoY
|
|
|
SNY
Sanofi
|
105.31B
|
Composite
53.2
Moat
-
|
-
No YoY
|
13.6%
-7.8
YoY
|
|
GSK
GSK plc
|
101.58B
|
Composite
56.9
Moat
-
|
-
No YoY
|
21.9%
+4.3
YoY
|
|
MDT
Medtronic plc.
|
100.09B
|
Composite
69.0
Moat
-
|
-
No YoY
|
19.5%
+2.4
YoY
|
|
94.77B
|
Composite
53.6
Moat
65.3
|
-
No YoY
|
15.8%
+0.9
YoY
|
|
|
91.09B
|
Composite
53.6
Moat
-
|
-
No YoY
|
1.2%
-0.1
YoY
|
|
|
83.24B
|
Composite
67.5
Moat
-
|
-
No YoY
|
19.8%
+1.9
YoY
|
|
|
80.98B
|
Composite
57.3
Moat
-
|
-
No YoY
|
4.1%
-1.1
YoY
|
|
|
75.59B
|
Composite
69.3
Moat
-
|
-
No YoY
|
25.8%
-2.3
YoY
|
|
|
75.14B
|
Composite
49.3
Moat
54.5
|
-
No YoY
|
3.3%
+0.6
YoY
|
|
|
52.57B
|
Composite
59.7
Moat
-
|
-
No YoY
|
10.6%
+2.0
YoY
|
|
|
COR
Cencora, Inc.
|
49.74B
|
Composite
53.4
Moat
-
|
-
No YoY
|
1.2%
+0.2
YoY
|
|
ARGX
argenx SE
|
48.72B
|
Composite
67.8
Moat
-
|
490.0
+399.2
YoY
|
-0.8%
+33.5
YoY
|
|
47.65B
|
Composite
66.7
Moat
80.0
|
-
No YoY
|
27.0%
-0.2
YoY
|
|
|
ZTS
Zoetis Inc.
|
46.95B
|
Composite
71.9
Moat
-
|
-
No YoY
|
38.0%
+1.4
YoY
|
|
45.14B
|
Composite
66.4
Moat
-
|
-
No YoY
|
31.6%
+2.7
YoY
|
|
|
43.64B
|
Composite
60.8
Moat
69.5
|
-
No YoY
|
13.7%
-0.5
YoY
|
|
|
43.39B
|
Composite
54.6
Moat
48.2
|
-
No YoY
|
1.0%
+0.1
YoY
|
|
|
41.93B
|
Composite
63.0
Moat
-
|
-
No YoY
|
22.9%
+2.6
YoY
|
|
|
HLN
Haleon plc
|
40.51B
|
Composite
66.1
Moat
67.5
|
-
No YoY
|
19.6%
+2.0
YoY
|
|
39.51B
|
Composite
70.4
Moat
-
|
3890.0
+3841.4
YoY
|
13.5%
+21.4
YoY
|
|
|
ONC
BeiGene, Ltd.
|
34.82B
|
Composite
73.3
Moat
-
|
224.2
+191.3
YoY
|
8.4%
+23.3
YoY
|
|
34.29B
|
Composite
65.9
Moat
78.9
|
-
No YoY
|
28.2%
-0.1
YoY
|
|
|
33.53B
|
Composite
65.0
Moat
-
|
-
No YoY
|
21.3%
-1.6
YoY
|
|
|
32.12B
|
Composite
42.8
Moat
-
|
49.28
-14.1
YoY
|
-42.1%
-34.8
YoY
|
|
|
ALC
Alcon Inc.
|
31.55B
|
Composite
61.3
Moat
-
|
-
No YoY
|
13.1%
-1.2
YoY
|
|
NTRA
Natera, Inc.
|
30.48B
|
Composite
45.1
Moat
-
|
42.71
+17.7
YoY
|
-13.1%
+28.1
YoY
|
|
RMD
ResMed Inc.
|
30.41B
|
Composite
69.6
Moat
-
|
-
No YoY
|
32.8%
+3.2
YoY
|
|
29.82B
|
Composite
57.5
Moat
67.4
|
-
No YoY
|
14.0%
-0.7
YoY
|
|
|
HUM
Humana Inc.
|
29.67B
|
Composite
47.8
Moat
-
|
-
No YoY
|
1.1%
-0.9
YoY
|
|
INSM
Insmed Incorporated
|
29.55B
|
Composite
46.2
Moat
-
|
25.16
+7.7
YoY
|
-1.9%
+0.2
YoY
|
|
RPRX
Royalty Pharma plc
|
29.26B
|
Composite
72.8
Moat
-
|
-
No YoY
|
65.6%
+8.5
YoY
|
|
BIIB
Biogen Inc.
|
28.25B
|
Composite
48.1
Moat
-
|
-
No YoY
|
25.0%
+1.4
YoY
|
|
27.90B
|
Composite
58.2
Moat
-
|
-
No YoY
|
13.4%
+0.0
YoY
|
|
|
VEEV
Veeva Systems Inc.
|
27.48B
|
Composite
66.8
Moat
-
|
-
No YoY
|
25.2%
+7.0
YoY
|
|
27.15B
|
Composite
22.9
Moat
41.6
|
-
No YoY
|
-3.9%
-5.9
YoY
|
|
|
26.97B
|
Composite
55.7
Moat
72.1
|
-
No YoY
|
27.8%
-1.3
YoY
|
|
|
26.15B
|
Composite
63.9
Moat
60.4
|
82.06
No YoY
|
8.0%
+5.1
YoY
|
|
|
25.33B
|
Composite
69.5
Moat
-
|
-
No YoY
|
46.9%
-3.4
YoY
|
|
|
BNTX
BioNTech SE
|
23.52B
|
Composite
62.5
Moat
-
|
-
No YoY
|
-21.6%
-45.3
YoY
|
|
DXCM
DexCom, Inc.
|
23.50B
|
Composite
71.8
Moat
-
|
-
No YoY
|
19.6%
+4.7
YoY
|
|
22.75B
|
Composite
63.7
Moat
-
|
-
No YoY
|
20.1%
-0.3
YoY
|
|
|
21.16B
|
Composite
62.8
Moat
58.8
|
-
No YoY
|
10.9%
+2.1
YoY
|
|
|
21.13B
|
Composite
62.6
Moat
64.4
|
-
No YoY
|
14.5%
+0.9
YoY
|
|
|
ILMN
Illumina, Inc.
|
20.99B
|
Composite
64.3
Moat
-
|
-
No YoY
|
18.8%
+5.1
YoY
|
|
20.96B
|
Composite
69.4
Moat
-
|
-
No YoY
|
17.6%
+0.8
YoY
|
|
|
20.63B
|
Composite
49.2
Moat
-
|
69.86
-32.0
YoY
|
-38.3%
-13.1
YoY
|
|
|
20.03B
|
Composite
49.1
Moat
-
|
33.93
No YoY
|
-6.1%
+0.4
YoY
|
|
|
INCY
Incyte Corporation
|
19.53B
|
Composite
72.8
Moat
-
|
-
No YoY
|
26.1%
+23.7
YoY
|
|
MRNA
Moderna, Inc.
|
19.26B
|
Composite
47.0
Moat
-
|
28.06
-5.1
YoY
|
-1.6%
-0.3
YoY
|
|
VTRS
Viatris Inc.
|
18.36B
|
Composite
43.6
Moat
-
|
-
No YoY
|
-18.6%
-21.3
YoY
|
|
GMAB
Genmab A/S
|
17.92B
|
Composite
72.4
Moat
-
|
-
No YoY
|
33.6%
+1.1
YoY
|
|
HOLX
Hologic, Inc.
|
16.97B
|
Composite
63.2
Moat
-
|
-
No YoY
|
19.1%
-4.0
YoY
|
|
16.72B
|
Composite
63.5
Moat
-
|
-
No YoY
|
16.5%
+2.3
YoY
|
|
|
16.13B
|
Composite
64.3
Moat
-
|
-
No YoY
|
16.6%
-3.4
YoY
|
|
|
15.56B
|
Composite
37.6
Moat
-
|
23.87
-4.1
YoY
|
-
No YoY
|
|
|
14.78B
|
Composite
66.3
Moat
-
|
-
No YoY
|
22.2%
-2.5
YoY
|
|
|
ASND
Ascendis Pharma A/S
|
14.57B
|
Composite
50.6
Moat
-
|
21.93
+11.7
YoY
|
-18.9%
+57.7
YoY
|
|
14.34B
|
Composite
72.5
Moat
-
|
-
No YoY
|
17.9%
+2.3
YoY
|
|
|
13.31B
|
Composite
46.6
Moat
-
|
34.82
+5.7
YoY
|
-90.2%
-42.6
YoY
|
|
|
13.28B
|
Composite
68.4
Moat
74.4
|
-
No YoY
|
14.8%
+3.6
YoY
|
|
|
13.21B
|
Composite
45.4
Moat
-
|
15.70
+5.8
YoY
|
-1.1%
+1.5
YoY
|
|
|
PEN
Penumbra, Inc.
|
12.72B
|
Composite
67.5
Moat
75.8
|
40.54
No YoY
|
13.5%
+6.3
YoY
|
|
DVA
DaVita Inc.
|
12.60B
|
Composite
52.9
Moat
-
|
-
No YoY
|
14.7%
-0.5
YoY
|
|
12.47B
|
Composite
53.7
Moat
-
|
55.04
-35.9
YoY
|
-40.5%
+26.9
YoY
|
|
|
12.41B
|
Composite
53.4
Moat
-
|
-
No YoY
|
12.6%
-8.1
YoY
|
|
|
12.33B
|
Composite
54.2
Moat
-
|
24.40
+0.9
YoY
|
-31.3%
-28.5
YoY
|
|
|
12.23B
|
Composite
30.7
Moat
40.5
|
42.02
-1.1
YoY
|
-44.4%
+15.6
YoY
|
|
|
12.19B
|
Composite
62.8
Moat
-
|
-
No YoY
|
21.1%
-0.1
YoY
|
|
|
12.06B
|
Composite
58.4
Moat
-
|
-
No YoY
|
15.3%
-1.5
YoY
|
|
|
11.99B
|
Composite
55.2
Moat
-
|
-
No YoY
|
5.3%
-0.3
YoY
|
|
|
11.92B
|
Composite
56.6
Moat
74.8
|
-
No YoY
|
16.7%
-1.4
YoY
|
|
|
EXEL
Exelixis, Inc.
|
11.62B
|
Composite
66.9
Moat
-
|
-
No YoY
|
38.5%
+6.7
YoY
|
|
GMED
Globus Medical, Inc.
|
11.51B
|
Composite
64.0
Moat
-
|
-
No YoY
|
16.3%
+7.6
YoY
|
|
11.35B
|
Composite
54.5
Moat
-
|
-
No YoY
|
9.3%
+1.7
YoY
|
|
|
11.33B
|
Composite
55.2
Moat
-
|
29.47
-2.5
YoY
|
-26.5%
+38.9
YoY
|
|
|
11.21B
|
Composite
57.7
Moat
66.5
|
-
No YoY
|
22.1%
-1.3
YoY
|
|
|
PODD
Insulet Corporation
|
11.11B
|
Composite
67.2
Moat
-
|
139.2
No YoY
|
17.5%
+2.6
YoY
|
|
RVTY
Revvity, Inc.
|
11.08B
|
Composite
58.8
Moat
-
|
-
No YoY
|
12.5%
-0.1
YoY
|
|
10.92B
|
Composite
69.9
Moat
-
|
17.65
-13.8
YoY
|
11.9%
+181.1
YoY
|
|
|
10.89B
|
Composite
64.2
Moat
-
|
35.15
No YoY
|
1.8%
+0.2
YoY
|
|
|
10.63B
|
Composite
62.5
Moat
-
|
-
No YoY
|
17.7%
+1.7
YoY
|
|
|
10.46B
|
Composite
66.8
Moat
-
|
-
No YoY
|
16.6%
-0.1
YoY
|
|
|
10.42B
|
Composite
59.5
Moat
-
|
-
No YoY
|
11.5%
+0.8
YoY
|
|
|
ABVX
Abivax SA
|
10.26B
|
Composite
40.0
Moat
-
|
11.23
-21.0
YoY
|
-
No YoY
|
|
10.19B
|
Composite
60.7
Moat
-
|
-
No YoY
|
8.4%
0.0
YoY
|
|
|
10.00B
|
Composite
38.0
Moat
51.2
|
185.2
No YoY
|
1.7%
-2.5
YoY
|
|
|
ICLR
ICON plc
|
9.54B
|
Composite
55.9
Moat
-
|
-
No YoY
|
14.7%
+1.8
YoY
|
|
9.42B
|
Composite
37.8
Moat
-
|
35.75
+27.0
YoY
|
-23.4%
+28.2
YoY
|
|
|
MASI
Masimo Corporation
|
9.35B
|
Composite
48.6
Moat
60.7
|
-
No YoY
|
20.3%
+18.5
YoY
|
|
9.24B
|
Composite
40.6
Moat
-
|
32.62
+14.8
YoY
|
-7.0%
+22.1
YoY
|
|
|
9.03B
|
Composite
44.0
Moat
-
|
-
No YoY
|
1.6%
-2.6
YoY
|
|
|
8.94B
|
Composite
51.6
Moat
61.2
|
-
No YoY
|
12.7%
+1.7
YoY
|
|
|
TEM
Tempus AI, Inc.
|
8.88B
|
Composite
44.7
Moat
-
|
28.45
+17.4
YoY
|
-19.9%
+79.8
YoY
|
|
8.75B
|
Composite
70.9
Moat
-
|
71.91
+26.7
YoY
|
41.4%
+5.9
YoY
|
|
|
IBRX
ImmunityBio, Inc.
|
8.65B
|
Composite
46.8
Moat
-
|
4.59
-4.1
YoY
|
-2.3%
+21.1
YoY
|
|
NUVL
Nuvalent, Inc.
|
8.23B
|
Composite
54.1
Moat
-
|
59.82
-12.7
YoY
|
-
No YoY
|
|
HSIC
Henry Schein, Inc.
|
8.03B
|
Composite
62.2
Moat
-
|
-
No YoY
|
5.8%
-0.0
YoY
|
|
ATR
AptarGroup, Inc.
|
7.98B
|
Composite
62.7
Moat
-
|
-
No YoY
|
13.5%
-0.7
YoY
|
|
GKOS
Glaukos Corporation
|
7.88B
|
Composite
54.9
Moat
-
|
62.41
+1.0
YoY
|
-28.2%
+11.1
YoY
|
|
7.69B
|
Composite
71.3
Moat
-
|
-
No YoY
|
58.5%
+4.1
YoY
|
|
|
QGEN
Qiagen N.V.
|
7.47B
|
Composite
63.8
Moat
-
|
-
No YoY
|
24.9%
+14.8
YoY
|
|
PCVX
Vaxcyte, Inc.
|
7.43B
|
Composite
48.1
Moat
-
|
46.32
+2.6
YoY
|
-
No YoY
|
|
TECH
Bio-Techne Corp
|
7.42B
|
Composite
71.5
Moat
-
|
-
No YoY
|
19.9%
-1.4
YoY
|
|
RGEN
Repligen Corporation
|
7.13B
|
Composite
63.8
Moat
-
|
-
No YoY
|
8.1%
+13.1
YoY
|
|
7.10B
|
Composite
48.9
Moat
-
|
30.15
-13.6
YoY
|
-8.9%
-3.5
YoY
|
|
|
7.10B
|
Composite
65.9
Moat
-
|
-
No YoY
|
16.9%
+4.1
YoY
|
|
|
6.99B
|
Composite
63.3
Moat
66.3
|
-
No YoY
|
8.5%
-2.0
YoY
|
|
|
6.93B
|
Composite
62.1
Moat
-
|
-
No YoY
|
8.5%
-2.0
YoY
|
|
|
ACLX
Arcellx, Inc.
|
6.75B
|
Composite
51.7
Moat
-
|
84.45
+53.7
YoY
|
-1.3%
+80.2
YoY
|
|
CELC
Celcuity Inc.
|
6.74B
|
Composite
42.5
Moat
-
|
33.80
-6.5
YoY
|
-
No YoY
|
|
6.71B
|
Composite
67.6
Moat
-
|
48.43
+33.3
YoY
|
-4.2%
+21.8
YoY
|
|
|
6.70B
|
Composite
64.1
Moat
-
|
92.11
+9.0
YoY
|
12.7%
+3.9
YoY
|
|
|
6.69B
|
Composite
52.0
Moat
-
|
58.37
+32.0
YoY
|
-3.4%
-61.6
YoY
|
|
|
BRKR
Bruker Corporation
|
6.66B
|
Composite
60.5
Moat
-
|
-
No YoY
|
6.3%
-5.0
YoY
|
|
6.59B
|
Composite
50.5
Moat
-
|
33.78
+9.5
YoY
|
-1.0%
+1.0
YoY
|
|
|
6.35B
|
Composite
58.6
Moat
-
|
45.98
+5.2
YoY
|
-145.1%
-108.7
YoY
|
|
|
6.32B
|
Composite
52.5
Moat
70.9
|
36.50
-27.0
YoY
|
-
No YoY
|
|
|
OSCR
Oscar Health, Inc.
|
6.28B
|
Composite
27.6
Moat
-
|
112.9
No YoY
|
-3.4%
-4.0
YoY
|
|
BLTE
Belite Bio, Inc
|
6.15B
|
Composite
53.2
Moat
-
|
59.58
+24.1
YoY
|
-
No YoY
|
|
6.13B
|
Composite
51.3
Moat
-
|
40.73
+21.5
YoY
|
-25.0%
No YoY
|
|
|
6.11B
|
Composite
53.8
Moat
-
|
61.39
+14.5
YoY
|
-49.9%
No YoY
|
|
|
CGON
CG Oncology, Inc.
|
6.09B
|
Composite
48.7
Moat
-
|
113.1
+63.8
YoY
|
-47.2%
+53.5
YoY
|
|
5.95B
|
Composite
49.5
Moat
-
|
16.58
-4.2
YoY
|
-
No YoY
|
|
|
ALKS
Alkermes plc
|
5.90B
|
Composite
68.2
Moat
-
|
-
No YoY
|
17.2%
-9.8
YoY
|
|
AVTR
Avantor, Inc.
|
5.76B
|
Composite
46.3
Moat
-
|
-
No YoY
|
8.3%
-1.1
YoY
|
|
5.67B
|
Composite
48.3
Moat
-
|
233.6
No YoY
|
3.1%
-1.2
YoY
|
|
|
CHE
Chemed Corp
|
5.65B
|
Composite
62.2
Moat
-
|
-
No YoY
|
13.4%
-1.7
YoY
|
|
5.62B
|
Composite
50.7
Moat
-
|
26.11
+3.0
YoY
|
-4.0%
+2.9
YoY
|
|
|
5.57B
|
Composite
59.7
Moat
-
|
-
No YoY
|
20.2%
-9.1
YoY
|
|
|
GRFS
Grifols, S.A.
|
5.54B
|
Composite
43.0
Moat
-
|
4879.4
No YoY
|
16.0%
+5.1
YoY
|
|
IMVT
Immunovant, Inc.
|
5.54B
|
Composite
53.5
Moat
-
|
22.79
-12.8
YoY
|
-
No YoY
|
|
5.51B
|
Composite
60.7
Moat
-
|
127.0
+60.6
YoY
|
49.5%
+67.7
YoY
|
|
|
5.48B
|
Composite
70.4
Moat
-
|
-
No YoY
|
5.9%
-14.4
YoY
|
|
|
5.45B
|
Composite
32.9
Moat
-
|
-
No YoY
|
2.9%
-15.0
YoY
|
|
|
PACS
PACS Group, Inc.
|
5.29B
|
Composite
54.8
Moat
-
|
-
No YoY
|
5.9%
+2.8
YoY
|
|
5.28B
|
Composite
63.4
Moat
-
|
93.54
+53.6
YoY
|
-48.4%
-46.8
YoY
|
|
|
5.26B
|
Composite
66.8
Moat
-
|
56.17
+49.1
YoY
|
5.5%
+26.6
YoY
|
|
|
5.19B
|
Composite
54.5
Moat
-
|
-
No YoY
|
14.6%
-3.9
YoY
|
|
|
5.06B
|
Composite
42.0
Moat
-
|
68.72
-91.3
YoY
|
-13.3%
+46.8
YoY
|
|
|
4.87B
|
Composite
47.4
Moat
-
|
41.47
-9.2
YoY
|
-13.7%
-9.4
YoY
|
|
|
DOCS
Doximity, Inc.
|
4.81B
|
Composite
68.1
Moat
-
|
-
No YoY
|
40.3%
+4.2
YoY
|
|
4.67B
|
Composite
50.5
Moat
-
|
42.25
-14.3
YoY
|
-16.3%
+0.7
YoY
|
|
|
4.64B
|
Composite
72.9
Moat
-
|
-
No YoY
|
15.3%
+1.5
YoY
|
|
|
4.55B
|
Composite
41.9
Moat
-
|
71.91
+31.6
YoY
|
-95.3%
+230.8
YoY
|
|
|
RDNT
RadNet, Inc.
|
4.55B
|
Composite
52.6
Moat
-
|
-
No YoY
|
6.1%
+0.3
YoY
|
|
4.55B
|
Composite
61.9
Moat
-
|
88.50
+38.8
YoY
|
5.4%
-1.0
YoY
|
|
|
4.47B
|
Composite
56.6
Moat
75.3
|
24.08
No YoY
|
33.8%
+6.7
YoY
|
|
|
4.41B
|
Composite
55.0
Moat
-
|
-
No YoY
|
8.7%
+3.2
YoY
|
|
|
4.38B
|
Composite
63.4
Moat
-
|
17.31
No YoY
|
11.4%
+22.2
YoY
|
|
|
4.29B
|
Composite
53.5
Moat
-
|
-
No YoY
|
12.4%
+3.1
YoY
|
|
|
ORKA
ARCA biopharma Inc
|
4.18B
|
Composite
58.9
Moat
-
|
77.94
No YoY
|
-
No YoY
|
|
4.16B
|
Composite
65.6
Moat
-
|
18.73
-5.6
YoY
|
-12.8%
-11.4
YoY
|
|
|
4.10B
|
Composite
56.6
Moat
-
|
32.04
-79.1
YoY
|
-4.9%
+14.5
YoY
|
|
|
3.98B
|
Composite
51.5
Moat
-
|
51.75
+10.2
YoY
|
-
No YoY
|
|
|
3.85B
|
Composite
67.8
Moat
-
|
43.86
-5.9
YoY
|
9.8%
+1.0
YoY
|
|
|
3.82B
|
Composite
68.3
Moat
-
|
-
No YoY
|
24.2%
+11.1
YoY
|
|
|
INDV
Indivior PLC
|
3.81B
|
Composite
51.5
Moat
-
|
16.40
-2662.6
YoY
|
21.1%
+2.0
YoY
|
|
3.77B
|
Composite
48.6
Moat
-
|
64.64
-43.5
YoY
|
0.4%
+4.1
YoY
|
|
|
3.75B
|
Composite
35.4
Moat
-
|
30.39
-93.0
YoY
|
-5203.4%
No YoY
|
|
|
LQDA
Liquidia Corporation
|
3.75B
|
Composite
63.0
Moat
-
|
22.67
-1.5
YoY
|
-8.7%
-4.5
YoY
|
|
3.73B
|
Composite
67.2
Moat
-
|
-
No YoY
|
43.8%
+4.1
YoY
|
|
|
3.72B
|
Composite
59.5
Moat
-
|
-
No YoY
|
12.2%
+0.7
YoY
|
|
|
3.71B
|
Composite
67.7
Moat
-
|
14.85
+11.6
YoY
|
2.2%
-8.2
YoY
|
|
|
3.71B
|
Composite
36.8
Moat
-
|
58.56
+6.8
YoY
|
-36.2%
+20.0
YoY
|
|
|
LIVN
LivaNova PLC
|
3.62B
|
Composite
47.4
Moat
-
|
-
No YoY
|
14.4%
+4.1
YoY
|
|
3.56B
|
Composite
51.2
Moat
-
|
63.13
+34.2
YoY
|
-10.0%
-6.2
YoY
|
|
|
OGN
Organon & Co.
|
3.50B
|
Composite
40.3
Moat
-
|
-
No YoY
|
20.7%
-2.5
YoY
|
|
ERAS
Erasca, Inc.
|
3.39B
|
Composite
56.5
Moat
68.1
|
32.72
-4.3
YoY
|
-
No YoY
|
|
3.39B
|
Composite
67.8
Moat
-
|
23.54
-10.7
YoY
|
-3.5%
-0.3
YoY
|
|
|
3.27B
|
Composite
50.3
Moat
-
|
69.04
+39.3
YoY
|
-1.6%
-0.4
YoY
|
|
|
3.26B
|
Composite
55.8
Moat
-
|
-
No YoY
|
6.0%
-0.5
YoY
|
|
|
VCYT
Veracyte, Inc.
|
3.25B
|
Composite
61.4
Moat
-
|
67.23
No YoY
|
14.3%
+9.8
YoY
|
|
ALMS
Alumis Inc.
|
3.24B
|
Composite
40.4
Moat
-
|
13.56
+9.0
YoY
|
-
No YoY
|
|
3.24B
|
Composite
54.9
Moat
-
|
29.40
-66.3
YoY
|
-2.7%
+3.8
YoY
|
|
|
3.22B
|
Composite
28.6
Moat
42.9
|
67.13
No YoY
|
0.5%
-1.2
YoY
|
|
|
3.13B
|
Composite
49.6
Moat
-
|
28.73
-6.0
YoY
|
-59.5%
-56.4
YoY
|
|
|
ICUI
ICU Medical, Inc.
|
3.04B
|
Composite
54.2
Moat
-
|
41.14
No YoY
|
4.8%
+0.7
YoY
|
|
3.03B
|
Composite
44.8
Moat
-
|
-
No YoY
|
-5.1%
-16.6
YoY
|
|
|
3.03B
|
Composite
57.4
Moat
-
|
-
No YoY
|
96.5%
+80.5
YoY
|
|
|
3.01B
|
Composite
63.5
Moat
-
|
-
No YoY
|
1.0%
-0.3
YoY
|
|
|
2.99B
|
Composite
59.4
Moat
-
|
-
No YoY
|
12.9%
+0.1
YoY
|
|
|
2.90B
|
Composite
52.8
Moat
-
|
26.36
+18.5
YoY
|
-
No YoY
|
|
|
2.89B
|
Composite
51.4
Moat
49.6
|
306.9
+153.4
YoY
|
-17.2%
+14.6
YoY
|
|
|
2.85B
|
Composite
58.5
Moat
-
|
56.02
No YoY
|
1.7%
+4.2
YoY
|
|
|
2.78B
|
Composite
52.5
Moat
-
|
90.90
+20.4
YoY
|
-
No YoY
|
|
|
2.75B
|
Composite
61.1
Moat
-
|
42.11
+18.9
YoY
|
-15.7%
+50.2
YoY
|
|
|
2.73B
|
Composite
69.5
Moat
-
|
50.61
-31.0
YoY
|
7.8%
No YoY
|
|
|
2.71B
|
Composite
35.5
Moat
-
|
17.19
-5.0
YoY
|
-
No YoY
|
|
|
WRBY
Warby Parker Inc.
|
2.70B
|
Composite
53.1
Moat
-
|
96.17
No YoY
|
-0.6%
+3.3
YoY
|
|
GRAL
GRAIL, Inc.
|
2.70B
|
Composite
32.9
Moat
-
|
15.87
+13.9
YoY
|
-3.6%
+2.5
YoY
|
|
2.63B
|
Composite
63.3
Moat
-
|
-
No YoY
|
8.7%
+1.8
YoY
|
|
|
2.62B
|
Composite
45.6
Moat
-
|
57.10
+36.2
YoY
|
-
No YoY
|
|
|
IRON
Disc Medicine, Inc.
|
2.62B
|
Composite
55.2
Moat
-
|
62.59
+3.7
YoY
|
-
No YoY
|
|
2.58B
|
Composite
61.9
Moat
-
|
24.39
+11.2
YoY
|
-3.2%
+62.1
YoY
|
|
|
2.57B
|
Composite
43.7
Moat
-
|
17.67
+3.1
YoY
|
-79.5%
+16.2
YoY
|
|
|
2.57B
|
Composite
63.3
Moat
-
|
-
No YoY
|
30.7%
+0.3
YoY
|
|
|
2.53B
|
Composite
63.9
Moat
-
|
-
No YoY
|
14.8%
+1.5
YoY
|
|
|
2.52B
|
Composite
70.6
Moat
-
|
363.7
+311.0
YoY
|
17.9%
+9.4
YoY
|
|
|
IMNM
Immunome, Inc.
|
2.51B
|
Composite
50.7
Moat
-
|
23.54
-195.5
YoY
|
-17.0%
-14.9
YoY
|
|
2.48B
|
Composite
58.9
Moat
-
|
32.78
-21.9
YoY
|
-72.8%
-26.1
YoY
|
|
|
2.47B
|
Composite
66.8
Moat
-
|
-
No YoY
|
27.2%
+3.4
YoY
|
|
|
2.45B
|
Composite
53.3
Moat
-
|
51.39
+1.8
YoY
|
-
No YoY
|
|
|
NKTR
Nektar Therapeutics
|
2.44B
|
Composite
46.9
Moat
-
|
17.43
-1.5
YoY
|
-1.3%
+0.2
YoY
|
|
2.42B
|
Composite
53.3
Moat
-
|
14.30
-20.7
YoY
|
-
No YoY
|
|
|
ADMA
ADMA Biologics Inc
|
2.40B
|
Composite
62.8
Moat
-
|
17.45
+12.0
YoY
|
37.5%
+4.9
YoY
|
|
2.40B
|
Composite
47.9
Moat
-
|
37.64
+7.7
YoY
|
-19.7%
+18.8
YoY
|
|
|
2.35B
|
Composite
58.1
Moat
-
|
28.02
+1.4
YoY
|
-20.6%
+66.2
YoY
|
|
|
2.34B
|
Composite
61.8
Moat
47.5
|
28.19
-31.3
YoY
|
-6.4%
-9.0
YoY
|
|
|
ZLAB
Zai Lab Limited
|
2.32B
|
Composite
54.5
Moat
-
|
43.54
-5.3
YoY
|
-49.9%
+18.8
YoY
|
|
AXGN
AxoGen, Inc.
|
2.31B
|
Composite
53.6
Moat
-
|
65.13
+28.7
YoY
|
-3.5%
-1.7
YoY
|
|
2.30B
|
Composite
56.3
Moat
-
|
-
No YoY
|
-5.1%
-9.0
YoY
|
|
|
2.26B
|
Composite
65.9
Moat
-
|
74.01
+25.0
YoY
|
39.0%
+39.5
YoY
|
|
|
2.25B
|
Composite
30.4
Moat
-
|
-
No YoY
|
11.7%
-4.8
YoY
|
|
|
2.22B
|
Composite
55.3
Moat
-
|
81.68
+51.7
YoY
|
-80.8%
-79.1
YoY
|
|
|
2.22B
|
Composite
42.7
Moat
-
|
55.16
+7.8
YoY
|
-27.8%
-7.2
YoY
|
|
|
2.20B
|
Composite
55.3
Moat
-
|
79.00
+38.9
YoY
|
-29.9%
-41.4
YoY
|
|
|
XRAY
DENTSPLY SIRONA Inc.
|
2.20B
|
Composite
33.6
Moat
-
|
-
No YoY
|
6.9%
+1.9
YoY
|
|
2.16B
|
Composite
67.2
Moat
-
|
125.7
+66.9
YoY
|
37.1%
+29.2
YoY
|
|
|
2.12B
|
Composite
49.8
Moat
-
|
43.17
+8.2
YoY
|
-5.2%
-2.5
YoY
|
|
|
2.12B
|
Composite
43.6
Moat
-
|
18.53
+13.1
YoY
|
-18.5%
+11.6
YoY
|
|
|
2.11B
|
Composite
53.5
Moat
-
|
9.30
No YoY
|
20.1%
+0.8
YoY
|
|
|
2.07B
|
Composite
53.5
Moat
-
|
29.97
+0.2
YoY
|
-2.8%
+10.3
YoY
|
|
|
2.06B
|
Composite
70.5
Moat
-
|
1.56
+0.7
YoY
|
20.8%
+17.1
YoY
|
|
|
2.04B
|
Composite
51.2
Moat
-
|
-
No YoY
|
6.1%
+1.0
YoY
|
|
|
ZYME
Zymeworks Inc.
|
2.04B
|
Composite
56.7
Moat
-
|
24.62
-13.3
YoY
|
-1.6%
+0.2
YoY
|
|
2.02B
|
Composite
47.6
Moat
-
|
33.76
+2.4
YoY
|
-
No YoY
|
|
|
NEOG
Neogen Corporation
|
2.01B
|
Composite
47.0
Moat
-
|
-
No YoY
|
-0.2%
-6.5
YoY
|
|
2.01B
|
Composite
48.3
Moat
-
|
58.72
+10.0
YoY
|
-
No YoY
|
|
|
OMCL
Omnicell, Inc.
|
1.99B
|
Composite
55.5
Moat
-
|
-
No YoY
|
0.4%
+0.4
YoY
|
|
NBTX
Nanobiotix S.A.
|
1.98B
|
Composite
50.5
Moat
-
|
30.53
-41.9
YoY
|
5.9%
+95.0
YoY
|
|
1.98B
|
Composite
49.2
Moat
-
|
45.46
+26.9
YoY
|
-1.9%
+93.7
YoY
|
|
|
PHVS
Pharvaris N.V.
|
1.97B
|
Composite
49.0
Moat
-
|
28.04
-22.4
YoY
|
-
No YoY
|
|
ASTH
Astrana Health Inc.
|
1.96B
|
Composite
47.5
Moat
-
|
-
No YoY
|
4.4%
-1.7
YoY
|
|
1.95B
|
Composite
50.5
Moat
-
|
33.54
+23.0
YoY
|
-
No YoY
|
|
|
NVCR
NovoCure Limited
|
1.95B
|
Composite
50.6
Moat
-
|
436.8
+287.8
YoY
|
-23.5%
+4.7
YoY
|
|
ANAB
AnaptysBio, Inc.
|
1.93B
|
Composite
54.9
Moat
-
|
34.17
-4.7
YoY
|
-1.3%
+7.9
YoY
|
|
1.92B
|
Composite
52.2
Moat
-
|
20.54
-3.1
YoY
|
-10.4%
-5.8
YoY
|
|
|
MESO
Mesoblast Limited
|
1.91B
|
Composite
49.3
Moat
-
|
38.71
+23.2
YoY
|
-3.6%
+6.2
YoY
|
|
1.89B
|
Composite
64.1
Moat
-
|
18.55
No YoY
|
12.6%
+12.2
YoY
|
|
|
1.88B
|
Composite
60.2
Moat
65.6
|
-
No YoY
|
12.1%
+2.9
YoY
|
|
|
1.87B
|
Composite
45.7
Moat
-
|
-
No YoY
|
14.6%
-0.3
YoY
|
|
|
VCEL
Vericel Corporation
|
1.87B
|
Composite
69.2
Moat
78.1
|
-
No YoY
|
4.0%
+2.1
YoY
|
|
1.86B
|
Composite
48.3
Moat
-
|
92.55
+86.1
YoY
|
-1.6%
No YoY
|
|
|
GLPG
Galapagos NV
|
1.86B
|
Composite
59.5
Moat
-
|
116.9
+8.0
YoY
|
40.6%
+108.9
YoY
|
|
1.82B
|
Composite
45.2
Moat
-
|
25.45
-17.7
YoY
|
-1.6%
+12.8
YoY
|
|
|
1.82B
|
Composite
39.6
Moat
-
|
9.42
-7.8
YoY
|
-1657.2%
-1535.5
YoY
|
|
|
1.82B
|
Composite
72.5
Moat
-
|
-
No YoY
|
26.7%
-6.3
YoY
|
|
|
1.82B
|
Composite
53.8
Moat
-
|
-
No YoY
|
9.7%
+0.8
YoY
|
|
|
1.81B
|
Composite
46.4
Moat
-
|
19.86
+3.5
YoY
|
-8.7%
-0.5
YoY
|
|
|
1.81B
|
Composite
49.7
Moat
-
|
37.07
+6.0
YoY
|
-5.1%
+985.1
YoY
|
|
|
1.79B
|
Composite
56.9
Moat
-
|
33.29
+13.6
YoY
|
-56.2%
-38.0
YoY
|
|
|
1.78B
|
Composite
54.8
Moat
-
|
12.63
-10.5
YoY
|
-2.9%
-13.1
YoY
|
|
|
1.77B
|
Composite
54.5
Moat
-
|
56.51
-8.6
YoY
|
-
No YoY
|
|
|
1.76B
|
Composite
36.0
Moat
33.7
|
29.23
+3.6
YoY
|
-26.6%
-23.0
YoY
|
|
|
1.75B
|
Composite
63.8
Moat
-
|
-
No YoY
|
8.5%
+3.3
YoY
|
|
|
1.75B
|
Composite
45.9
Moat
23.8
|
24.93
+4.5
YoY
|
-
No YoY
|
|
|
1.75B
|
Composite
39.9
Moat
-
|
41.51
+22.9
YoY
|
-
No YoY
|
|
|
1.73B
|
Composite
31.0
Moat
-
|
114.4
+35.7
YoY
|
-4.9%
+1.1
YoY
|
|
|
ARDX
Ardelyx, Inc.
|
1.72B
|
Composite
59.0
Moat
-
|
66.98
+42.3
YoY
|
-10.1%
-1.7
YoY
|
|
1.71B
|
Composite
66.5
Moat
-
|
-
No YoY
|
15.3%
-1.4
YoY
|
|
|
1.68B
|
Composite
48.5
Moat
-
|
28.52
-13.9
YoY
|
-3.4%
+0.5
YoY
|
|
|
NUVB
Nuvation Bio Inc.
|
1.67B
|
Composite
53.6
Moat
-
|
46.26
-61.6
YoY
|
-75.3%
No YoY
|
|
INVA
Innoviva, Inc.
|
1.67B
|
Composite
74.5
Moat
-
|
-
No YoY
|
38.5%
-8.0
YoY
|
|
AORT
Artivion, Inc.
|
1.66B
|
Composite
61.4
Moat
-
|
91.64
-163.7
YoY
|
6.1%
-3.9
YoY
|
|
1.66B
|
Composite
39.7
Moat
46.5
|
24.34
+0.9
YoY
|
-6.8%
+1.8
YoY
|
|
|
1.64B
|
Composite
45.6
Moat
-
|
27.49
-0.0
YoY
|
-8.7%
+2.9
YoY
|
|
|
1.64B
|
Composite
49.8
Moat
-
|
20.69
-7.1
YoY
|
-9.2%
+5.0
YoY
|
|
|
1.63B
|
Composite
59.5
Moat
-
|
63.67
+29.6
YoY
|
-1.1%
No YoY
|
|
|
PRGO
Perrigo Company plc
|
1.62B
|
Composite
41.3
Moat
-
|
-
No YoY
|
-26.4%
-33.5
YoY
|
|
1.56B
|
Composite
50.9
Moat
-
|
98.15
+71.2
YoY
|
-11.3%
+11.4
YoY
|
|
|
AHCO
AdaptHealth Corp.
|
1.56B
|
Composite
56.5
Moat
-
|
-
No YoY
|
8.5%
+1.2
YoY
|
|
1.56B
|
Composite
48.7
Moat
-
|
78.61
+18.0
YoY
|
-
No YoY
|
|
|
PGEN
Precigen, Inc.
|
1.56B
|
Composite
35.4
Moat
-
|
17.23
+6.0
YoY
|
-24.1%
-9.8
YoY
|
|
1.53B
|
Composite
54.0
Moat
-
|
178.5
No YoY
|
3.0%
-0.1
YoY
|
|
|
1.53B
|
Composite
44.6
Moat
31.3
|
9.07
-16.5
YoY
|
-331.7%
+60.1
YoY
|
|
|
1.53B
|
Composite
60.6
Moat
-
|
57.53
+27.3
YoY
|
-
No YoY
|
|
|
QURE
uniQure N.V.
|
1.52B
|
Composite
46.1
Moat
-
|
24.14
-26.7
YoY
|
-6.7%
+11.1
YoY
|
|
NVAX
Novavax, Inc.
|
1.52B
|
Composite
55.1
Moat
-
|
126.9
+117.4
YoY
|
40.3%
+76.8
YoY
|
|
BHVN
Biohaven Ltd.
|
1.51B
|
Composite
40.5
Moat
-
|
10.01
-3.8
YoY
|
-
No YoY
|
|
1.51B
|
Composite
50.4
Moat
-
|
4.76
-27.5
YoY
|
7.0%
+1.0
YoY
|
|
|
HROW
Harrow, Inc.
|
1.50B
|
Composite
64.6
Moat
-
|
25.54
No YoY
|
4.5%
+3.9
YoY
|
|
IMTX
Immatics N.V.
|
1.49B
|
Composite
51.5
Moat
-
|
45.90
+25.4
YoY
|
-24.8%
-22.9
YoY
|
|
GLTO
Galecto, Inc.
|
1.49B
|
Composite
49.1
Moat
-
|
9.13
-1.6
YoY
|
-
No YoY
|
|
1.48B
|
Composite
30.9
Moat
-
|
19.60
-0.1
YoY
|
-3.3%
+10.9
YoY
|
|
|
1.47B
|
Composite
51.7
Moat
-
|
-
No YoY
|
-32.0%
-27.9
YoY
|
|
|
PGNY
Progyny, Inc.
|
1.46B
|
Composite
61.7
Moat
-
|
-
No YoY
|
6.6%
+0.8
YoY
|
|
1.46B
|
Composite
57.9
Moat
-
|
4.03
-8.1
YoY
|
34.4%
No YoY
|
|
|
1.46B
|
Composite
50.3
Moat
-
|
11.01
+1.7
YoY
|
-1.5%
+0.9
YoY
|
|
|
1.46B
|
Composite
53.4
Moat
-
|
-
No YoY
|
-2.9%
+8.0
YoY
|
|
|
1.45B
|
Composite
49.1
Moat
-
|
40.36
+11.8
YoY
|
-33.7%
+9.3
YoY
|
|
|
1.42B
|
Composite
42.4
Moat
-
|
142.7
No YoY
|
6.8%
+2.7
YoY
|
|
|
ATRC
AtriCure, Inc.
|
1.41B
|
Composite
55.1
Moat
-
|
65.64
-38.1
YoY
|
-0.6%
+8.0
YoY
|
|
1.39B
|
Composite
49.2
Moat
47.8
|
24.00
-99.7
YoY
|
-5.0%
-4.0
YoY
|
|
|
GHRS
GH Research PLC
|
1.39B
|
Composite
50.8
Moat
-
|
42.38
-15.8
YoY
|
-
No YoY
|
|
1.37B
|
Composite
62.5
Moat
-
|
37.41
+5.1
YoY
|
-
No YoY
|
|
|
1.37B
|
Composite
45.7
Moat
-
|
17.31
-11.0
YoY
|
-4.6%
No YoY
|
|
|
1.35B
|
Composite
53.2
Moat
-
|
-
No YoY
|
-4.0%
-12.7
YoY
|
|
|
1.33B
|
Composite
29.1
Moat
-
|
38.97
+22.9
YoY
|
-219.8%
-136.9
YoY
|
|
|
1.32B
|
Composite
51.0
Moat
-
|
49.92
+12.4
YoY
|
-
No YoY
|
|
|
1.32B
|
Composite
24.8
Moat
-
|
16.62
-10.5
YoY
|
-
No YoY
|
|
|
1.32B
|
Composite
73.0
Moat
-
|
-
No YoY
|
5.6%
+1.1
YoY
|
|
|
1.30B
|
Composite
50.9
Moat
-
|
24.53
+10.9
YoY
|
-
No YoY
|
|
|
URGN
UroGen Pharma Ltd.
|
1.28B
|
Composite
47.4
Moat
-
|
29.35
+7.8
YoY
|
-1.1%
+78.2
YoY
|
|
TDOC
Teladoc Health, Inc.
|
1.26B
|
Composite
48.9
Moat
-
|
-
No YoY
|
-10.4%
-2.3
YoY
|
|
1.25B
|
Composite
66.0
Moat
-
|
-
No YoY
|
26.4%
-3.0
YoY
|
|
|
1.24B
|
Composite
52.3
Moat
-
|
3.42
No YoY
|
5.4%
+0.0
YoY
|
|
|
1.23B
|
Composite
37.7
Moat
-
|
46.11
-97.2
YoY
|
-
No YoY
|
|
|
1.23B
|
Composite
44.4
Moat
-
|
176.5
No YoY
|
-7.7%
+2.8
YoY
|
|
|
1.19B
|
Composite
49.3
Moat
-
|
37.31
+3.5
YoY
|
-10.8%
+9.4
YoY
|
|
|
1.19B
|
Composite
39.9
Moat
-
|
25.54
+9.2
YoY
|
-90.7%
-88.5
YoY
|
|
|
1.18B
|
Composite
41.1
Moat
-
|
3.73
-17.6
YoY
|
-
No YoY
|
|
|
AVNS
Avanos Medical, Inc.
|
1.16B
|
Composite
48.3
Moat
-
|
-
No YoY
|
-8.8%
-14.7
YoY
|
|
1.16B
|
Composite
41.8
Moat
-
|
2551.2
+2471.5
YoY
|
-9.1%
+3.8
YoY
|
|
|
EVO
Evotec SE
|
1.16B
|
Composite
41.7
Moat
38.8
|
-
No YoY
|
-9.9%
-6.5
YoY
|
|
CNMD
CONMED Corporation
|
1.15B
|
Composite
66.8
Moat
-
|
-
No YoY
|
9.5%
-5.9
YoY
|
|
1.15B
|
Composite
52.8
Moat
-
|
35.17
+12.8
YoY
|
-32.8%
+21.5
YoY
|
|
|
1.12B
|
Composite
36.7
Moat
-
|
35.26
+8.6
YoY
|
-3.4%
-1.7
YoY
|
|
|
IRMD
iRadimed Corporation
|
1.11B
|
Composite
73.6
Moat
-
|
-
No YoY
|
31.2%
+1.2
YoY
|
|
CDNA
CareDx, Inc.
|
1.11B
|
Composite
48.0
Moat
-
|
153.6
+14.3
YoY
|
-5.5%
+10.6
YoY
|
|
1.10B
|
Composite
31.2
Moat
-
|
13.49
+9.5
YoY
|
-10.2%
-4.3
YoY
|
|
|
1.10B
|
Composite
64.6
Moat
-
|
23.24
+4.8
YoY
|
-16.6%
+10.3
YoY
|
|
|
MNKD
MannKind Corporation
|
1.10B
|
Composite
63.9
Moat
-
|
25.41
-14.3
YoY
|
11.1%
-12.9
YoY
|
|
1.10B
|
Composite
52.8
Moat
-
|
33.43
No YoY
|
-1.9%
+1.1
YoY
|
|
|
1.08B
|
Composite
62.0
Moat
-
|
-
No YoY
|
19.5%
-8.6
YoY
|
|
|
SVRA
Savara, Inc.
|
1.08B
|
Composite
42.4
Moat
-
|
27.99
+1.5
YoY
|
-
No YoY
|
|
SEPN
Septerna, Inc.
|
1.08B
|
Composite
70.0
Moat
-
|
62.41
+35.0
YoY
|
-75.2%
+226.5
YoY
|
|
OMER
Omeros Corporation
|
1.07B
|
Composite
38.7
Moat
-
|
7.27
-19.8
YoY
|
-
No YoY
|
|
1.05B
|
Composite
56.0
Moat
-
|
-
No YoY
|
-30.2%
-31.9
YoY
|
|
|
1.05B
|
Composite
53.8
Moat
-
|
42.42
-46.2
YoY
|
-12.6%
-3.9
YoY
|
|
|
1.03B
|
Composite
55.8
Moat
-
|
59.45
+50.8
YoY
|
-2.8%
+4.8
YoY
|
|
|
1.01B
|
Composite
22.6
Moat
27.8
|
83.07
+45.6
YoY
|
-7.1%
-2.3
YoY
|
|
|
1.01B
|
Composite
53.7
Moat
-
|
13.37
-19.9
YoY
|
-5.0%
+240.3
YoY
|
|
|
1.00B
|
Composite
49.2
Moat
-
|
19.93
+1.8
YoY
|
-
No YoY
|
|
|
ALVO
Alvotech
|
1.00B
|
Composite
53.6
Moat
-
|
2.61
+2.2
YoY
|
14.2%
+18.1
YoY
|
|
SDGR
Schrodinger, Inc.
|
992.29M
|
Composite
40.9
Moat
-
|
26.85
-13.8
YoY
|
-65.2%
-64.2
YoY
|
|
974.20M
|
Composite
48.4
Moat
-
|
241.4
+122.9
YoY
|
-1.5%
+49.1
YoY
|
|
|
972.91M
|
Composite
59.1
Moat
-
|
-
No YoY
|
11.0%
+2.7
YoY
|
|
|
971.25M
|
Composite
52.7
Moat
-
|
8.20
-1.5
YoY
|
-
No YoY
|
|
|
CERT
Certara, Inc.
|
959.81M
|
Composite
59.3
Moat
-
|
-
No YoY
|
5.0%
+5.5
YoY
|
|
XNCR
Xencor, Inc.
|
954.10M
|
Composite
56.7
Moat
-
|
29.54
-61.9
YoY
|
-1.4%
+0.2
YoY
|
|
GERN
Geron Corporation
|
936.60M
|
Composite
55.8
Moat
-
|
22.32
-1.6
YoY
|
-2.3%
+816.1
YoY
|
|
930.20M
|
Composite
60.7
Moat
-
|
-
No YoY
|
2.6%
-11.3
YoY
|
|
|
NUTX
Nutex Health Inc.
|
926.16M
|
Composite
70.8
Moat
-
|
-
No YoY
|
28.7%
+29.3
YoY
|
|
924.90M
|
Composite
51.4
Moat
25.6
|
4.71
+3.7
YoY
|
-31.9%
-29.4
YoY
|
|
|
921.48M
|
Composite
55.1
Moat
60.7
|
46.24
-35.9
YoY
|
-3.5%
+2247.2
YoY
|
|
|
921.16M
|
Composite
55.4
Moat
-
|
25.80
-7.1
YoY
|
-3.6%
No YoY
|
|
|
911.99M
|
Composite
54.1
Moat
-
|
27.26
-1.9
YoY
|
-
No YoY
|
|
|
ANNX
Annexon, Inc.
|
897.04M
|
Composite
49.9
Moat
-
|
31.73
+6.0
YoY
|
-
No YoY
|
|
895.95M
|
Composite
33.0
Moat
-
|
11.90
-2.9
YoY
|
-4.9%
+4.8
YoY
|
|
|
ABSI
Absci Corporation
|
893.82M
|
Composite
45.9
Moat
-
|
18.63
+0.5
YoY
|
-24.0%
-7.5
YoY
|
|
892.20M
|
Composite
53.9
Moat
-
|
-
No YoY
|
9.8%
-1.8
YoY
|
|
|
886.38M
|
Composite
59.0
Moat
-
|
280.8
+199.2
YoY
|
-9.3%
-0.3
YoY
|
|
|
880.64M
|
Composite
53.3
Moat
-
|
68.34
+10.6
YoY
|
-
No YoY
|
|
|
874.60M
|
Composite
52.1
Moat
-
|
114.5
+77.4
YoY
|
-
No YoY
|
|
|
872.30M
|
Composite
61.9
Moat
-
|
91.91
+46.4
YoY
|
-65.9%
+26.9
YoY
|
|
|
867.50M
|
Composite
39.7
Moat
-
|
-
No YoY
|
1.2%
-2.8
YoY
|
|
|
TALK
Talkspace, Inc.
|
867.12M
|
Composite
58.1
Moat
-
|
90.70
+63.5
YoY
|
1.4%
+3.8
YoY
|
|
864.00M
|
Composite
51.1
Moat
-
|
22.69
+5.1
YoY
|
-11.3%
-7.0
YoY
|
|
|
861.55M
|
Composite
44.2
Moat
-
|
11.07
-5.3
YoY
|
-
No YoY
|
|
|
INMD
InMode Ltd.
|
861.05M
|
Composite
66.0
Moat
-
|
-
No YoY
|
23.1%
-5.4
YoY
|
|
PHAR
Pharming Group N.V.
|
860.79M
|
Composite
67.0
Moat
-
|
1122.4
+974.4
YoY
|
-1.2%
+7.9
YoY
|
|
AZTA
Azenta, Inc.
|
855.40M
|
Composite
41.7
Moat
-
|
40.43
No YoY
|
-3.6%
+3.3
YoY
|
|
848.70M
|
Composite
53.4
Moat
-
|
36.62
No YoY
|
-6.7%
-2.9
YoY
|
|
|
845.70M
|
Composite
33.1
Moat
38.9
|
28.25
-12.6
YoY
|
-19.3%
+19.0
YoY
|
|
|
KURA
Kura Oncology, Inc.
|
844.40M
|
Composite
51.1
Moat
-
|
40.76
-7.0
YoY
|
-3.6%
No YoY
|
|
843.72M
|
Composite
48.4
Moat
-
|
42.57
+13.0
YoY
|
-43.2%
+14.2
YoY
|
|
|
824.40M
|
Composite
50.6
Moat
-
|
10.41
-12.0
YoY
|
-
No YoY
|
|
|
806.40M
|
Composite
39.6
Moat
-
|
73.44
+66.2
YoY
|
16.4%
+17.7
YoY
|
|
|
794.59M
|
Composite
45.6
Moat
-
|
17.52
-5.1
YoY
|
-11703.7%
-8393.3
YoY
|
|
|
BIOA
BioAge Labs, Inc.
|
791.17M
|
Composite
35.5
Moat
-
|
82.53
+75.6
YoY
|
-
No YoY
|
|
787.60M
|
Composite
60.7
Moat
-
|
-
No YoY
|
40.1%
+12.9
YoY
|
|
|
784.50M
|
Composite
37.9
Moat
-
|
3.93
+1.9
YoY
|
-338.5%
-326.2
YoY
|
|
|
779.83M
|
Composite
73.1
Moat
-
|
87.90
No YoY
|
15.3%
-1.6
YoY
|
|
|
CBLL
CeriBell, Inc.
|
763.13M
|
Composite
45.5
Moat
-
|
66.56
+52.4
YoY
|
-65.6%
-4.9
YoY
|
|
747.40M
|
Composite
38.6
Moat
-
|
-
No YoY
|
-33.7%
-35.3
YoY
|
|
|
BVS
Bioventus Inc.
|
721.52M
|
Composite
58.2
Moat
-
|
26.76
No YoY
|
4.5%
+4.1
YoY
|
|
708.40M
|
Composite
46.0
Moat
46.1
|
17.87
+2.1
YoY
|
-12.3%
-7.0
YoY
|
|
|
EHAB
Enhabit, Inc.
|
698.46M
|
Composite
50.5
Moat
-
|
-
No YoY
|
4.5%
+0.9
YoY
|
|
HSTM
HealthStream, Inc.
|
687.70M
|
Composite
63.4
Moat
-
|
-
No YoY
|
6.7%
-0.6
YoY
|
|
BWAY
Brainsway Ltd.
|
686.37M
|
Composite
65.2
Moat
-
|
58.50
No YoY
|
3.4%
+19.0
YoY
|
|
685.93M
|
Composite
40.1
Moat
-
|
76.85
+56.9
YoY
|
-
No YoY
|
|
|
680.70M
|
Composite
51.1
Moat
-
|
14.00
-23.4
YoY
|
18.1%
+24.5
YoY
|
|
|
677.90M
|
Composite
61.4
Moat
-
|
15.97
+3.4
YoY
|
-6.3%
+136.3
YoY
|
|
|
TLRY
Tilray Brands, Inc.
|
675.14M
|
Composite
43.1
Moat
-
|
32.52
-68.6
YoY
|
-13.1%
+1.2
YoY
|
|
667.99M
|
Composite
48.5
Moat
-
|
36.15
-18.5
YoY
|
-
No YoY
|
|
|
667.59M
|
Composite
32.8
Moat
-
|
67.90
+49.7
YoY
|
-2.8%
+0.9
YoY
|
|
|
659.90M
|
Composite
39.5
Moat
-
|
19.85
-20.5
YoY
|
-3.8%
+54.2
YoY
|
|
|
ARVN
Arvinas, Inc.
|
651.76M
|
Composite
54.9
Moat
-
|
48.10
+4.6
YoY
|
-43.8%
+51.2
YoY
|
|
650.30M
|
Composite
64.4
Moat
-
|
11.97
-12.3
YoY
|
-3.7%
-1.9
YoY
|
|
|
649.16M
|
Composite
46.2
Moat
-
|
22.78
+7.3
YoY
|
-
No YoY
|
|
|
CRMD
CorMedix Inc.
|
636.40M
|
Composite
69.2
Moat
-
|
12.25
-11.5
YoY
|
-51.4%
+416.8
YoY
|
|
PSNL
Personalis, Inc.
|
635.39M
|
Composite
31.6
Moat
-
|
49.17
+24.8
YoY
|
-80.7%
-79.4
YoY
|
|
635.38M
|
Composite
47.2
Moat
-
|
334.7
No YoY
|
-10.2%
+4.2
YoY
|
|
|
ALT
Altimmune, Inc.
|
633.09M
|
Composite
47.9
Moat
-
|
19.82
-11.5
YoY
|
-5158.6%
-4962.6
YoY
|
|
NPCE
Neuropace, Inc.
|
615.18M
|
Composite
53.3
Moat
-
|
35.27
-5.2
YoY
|
-27.1%
+14.4
YoY
|
|
CABA
Cabaletta Bio, Inc.
|
608.18M
|
Composite
46.5
Moat
-
|
22.30
-31.8
YoY
|
-
No YoY
|
|
PRME
Prime Medicine, Inc.
|
604.06M
|
Composite
45.9
Moat
-
|
18.60
+9.8
YoY
|
-67.9%
No YoY
|
|
601.90M
|
Composite
46.7
Moat
-
|
37.70
-17.8
YoY
|
-19.1%
-17.9
YoY
|
|
|
ENGN
enGene Holdings Inc.
|
592.86M
|
Composite
39.9
Moat
-
|
23.43
-35.8
YoY
|
-
No YoY
|
|
PROK
ProKidney Corp.
|
591.80M
|
Composite
48.0
Moat
-
|
34.03
-14.3
YoY
|
-2416.8%
No YoY
|
|
586.73M
|
Composite
41.5
Moat
-
|
21.09
-17.3
YoY
|
-1.9%
+0.3
YoY
|
|
|
585.68M
|
Composite
47.3
Moat
-
|
121.3
+97.1
YoY
|
-6.2%
-28.5
YoY
|
|
|
CLYM
Climb Bio, Inc.
|
583.73M
|
Composite
57.1
Moat
-
|
116.4
+54.2
YoY
|
-
No YoY
|
|
583.55M
|
Composite
46.7
Moat
-
|
518.5
+444.0
YoY
|
-12.4%
-15.1
YoY
|
|
|
581.13M
|
Composite
50.1
Moat
-
|
-
No YoY
|
-1.2%
+26.9
YoY
|
|
|
MOVE
Movano Inc.
|
579.88M
|
Composite
31.3
Moat
-
|
4.21
+1.4
YoY
|
-23.9%
No YoY
|
|
PHR
Phreesia, Inc.
|
579.07M
|
Composite
64.9
Moat
42.9
|
32.44
+8.9
YoY
|
-13.8%
+24.5
YoY
|
|
576.42M
|
Composite
24.5
Moat
-
|
7.29
+3.5
YoY
|
24.4%
+53.4
YoY
|
|
|
SIBN
SI-BONE, Inc.
|
574.73M
|
Composite
48.3
Moat
-
|
144.9
+38.4
YoY
|
-11.1%
+10.0
YoY
|
|
573.22M
|
Composite
46.9
Moat
-
|
30.04
+16.9
YoY
|
-4.2%
+0.5
YoY
|
|
|
570.70M
|
Composite
69.4
Moat
-
|
-
No YoY
|
8.9%
+1.3
YoY
|
|
|
558.87M
|
Composite
61.2
Moat
-
|
45.59
+33.2
YoY
|
-277.4%
-80.2
YoY
|
|
|
MDXG
MiMedx Group, Inc
|
549.60M
|
Composite
72.2
Moat
-
|
44.23
-483.0
YoY
|
15.3%
-1.7
YoY
|
|
548.00M
|
Composite
39.1
Moat
-
|
14.11
-6.8
YoY
|
-18.9%
No YoY
|
|
|
547.08M
|
Composite
43.8
Moat
-
|
14.54
-3.9
YoY
|
-
No YoY
|
|
|
VALN
Valneva SE
|
546.89M
|
Composite
56.3
Moat
-
|
30.04
+22.6
YoY
|
-45.9%
+7.6
YoY
|
|
546.23M
|
Composite
59.5
Moat
-
|
74.81
+46.6
YoY
|
32.1%
No YoY
|
|
|
RGNX
REGENXBIO Inc.
|
537.80M
|
Composite
49.0
Moat
-
|
16.27
+1.1
YoY
|
-2.8%
+0.2
YoY
|
|
VSTM
Verastem, Inc.
|
527.90M
|
Composite
35.5
Moat
-
|
10.17
-8.9
YoY
|
-11.5%
+16.6
YoY
|
|
526.44M
|
Composite
51.8
Moat
-
|
22.72
-19.8
YoY
|
-
No YoY
|
|
|
525.72M
|
Composite
35.3
Moat
-
|
24.01
-20.9
YoY
|
-53.5%
-23.6
YoY
|
|
|
CERS
Cerus Corporation
|
523.00M
|
Composite
59.6
Moat
-
|
18.31
-29.6
YoY
|
-7.9%
+8.9
YoY
|
|
519.09M
|
Composite
43.7
Moat
-
|
37.88
-7.8
YoY
|
-5076.8%
-5071.3
YoY
|
|
|
516.40M
|
Composite
38.9
Moat
-
|
22.71
-6.5
YoY
|
-3.5%
-1.6
YoY
|
|
|
509.90M
|
Composite
49.9
Moat
-
|
-
No YoY
|
7.8%
+3.9
YoY
|
|
|
506.46M
|
Composite
48.1
Moat
-
|
28.69
+20.2
YoY
|
-
No YoY
|
|
|
STTK
Shattuck Labs, Inc.
|
504.89M
|
Composite
55.3
Moat
-
|
14.47
-4.8
YoY
|
-14.1%
+41.4
YoY
|
|
NGNE
Neurogene Inc.
|
504.86M
|
Composite
47.0
Moat
-
|
53.10
+7.1
YoY
|
-89.3%
No YoY
|
|
500.12M
|
Composite
50.5
Moat
-
|
95.41
+60.7
YoY
|
-32.8%
-16.0
YoY
|
|
|
497.50M
|
Composite
56.7
Moat
-
|
26.31
+13.3
YoY
|
-1.6%
+7.4
YoY
|
|
|
497.00M
|
Composite
40.7
Moat
-
|
32.91
+30.0
YoY
|
-155.4%
-143.2
YoY
|
|
|
495.30M
|
Composite
63.0
Moat
-
|
91.81
-9.6
YoY
|
-88.8%
-84.2
YoY
|
|
|
487.90M
|
Composite
45.6
Moat
-
|
8.68
-44.0
YoY
|
-8.3%
+1.4
YoY
|
|
|
OCGN
Ocugen, Inc.
|
487.46M
|
Composite
48.3
Moat
-
|
16.66
+9.0
YoY
|
-13.5%
-2.6
YoY
|
|
486.67M
|
Composite
50.5
Moat
-
|
15.58
-10.5
YoY
|
-20.0%
No YoY
|
|
|
486.48M
|
Composite
45.4
Moat
-
|
27.38
-12.7
YoY
|
-3611.0%
-1711.0
YoY
|
|
|
485.50M
|
Composite
67.8
Moat
-
|
119.0
+109.5
YoY
|
13.5%
+31.0
YoY
|
|
|
481.37M
|
Composite
46.4
Moat
-
|
106.5
+26.4
YoY
|
-12.1%
+3.3
YoY
|
|
|
KMDA
Kamada Ltd.
|
477.60M
|
Composite
59.0
Moat
-
|
25.29
No YoY
|
12.5%
+5.4
YoY
|
|
ADCT
ADC Therapeutics SA
|
476.97M
|
Composite
47.0
Moat
-
|
24.31
-3.9
YoY
|
-1.8%
+0.5
YoY
|
|
473.76M
|
Composite
53.2
Moat
-
|
1304.0
+1272.8
YoY
|
-24.8%
+14.7
YoY
|
|
|
471.78M
|
Composite
56.2
Moat
-
|
42.77
-5.1
YoY
|
-15.4%
No YoY
|
|
|
471.10M
|
Composite
55.5
Moat
-
|
6.50
-219.6
YoY
|
13.5%
+21.5
YoY
|
|
|
BBNX
Beta Bionics, Inc.
|
471.02M
|
Composite
44.7
Moat
-
|
51.63
+25.9
YoY
|
-71.5%
-2.0
YoY
|
|
ZURA
Zura Bio Limited
|
463.97M
|
Composite
53.1
Moat
-
|
75.44
-4.1
YoY
|
-
No YoY
|
|
461.56M
|
Composite
47.1
Moat
-
|
17.97
-6.5
YoY
|
-92.5%
-62.0
YoY
|
|
|
ANGO
AngioDynamics, Inc.
|
456.60M
|
Composite
43.8
Moat
-
|
66.22
+33.8
YoY
|
-8.2%
+2.9
YoY
|
|
452.44M
|
Composite
52.1
Moat
-
|
34.21
+14.5
YoY
|
-23.8%
+79.6
YoY
|
|
|
452.15M
|
Composite
57.2
Moat
-
|
40.27
-41.0
YoY
|
39.4%
No YoY
|
|
|
451.30M
|
Composite
42.3
Moat
-
|
30.54
-5.1
YoY
|
-12.3%
+2.2
YoY
|
|
|
442.30M
|
Composite
58.6
Moat
-
|
117.6
+79.8
YoY
|
-1.3%
+0.5
YoY
|
|
|
439.80M
|
Composite
42.8
Moat
-
|
28.93
-256.4
YoY
|
-70.0%
-49.5
YoY
|
|
|
435.20M
|
Composite
35.4
Moat
-
|
148.8
+145.8
YoY
|
-2.1%
0.0
YoY
|
|
|
434.50M
|
Composite
38.7
Moat
29.9
|
9.52
+0.9
YoY
|
-24.7%
+18.4
YoY
|
|
|
430.58M
|
Composite
49.8
Moat
-
|
49.73
+18.3
YoY
|
-254.4%
-9.8
YoY
|
|
|
429.10M
|
Composite
38.5
Moat
-
|
-
No YoY
|
-19.1%
+7.0
YoY
|
|
|
427.60M
|
Composite
37.6
Moat
-
|
195.5
No YoY
|
-1.2%
-0.7
YoY
|
|
|
425.66M
|
Composite
44.3
Moat
-
|
20.18
-13.2
YoY
|
-
No YoY
|
|
|
PRTC
PureTech Health plc
|
425.06M
|
Composite
47.0
Moat
-
|
32.80
-4.3
YoY
|
-31.5%
+163.4
YoY
|
|
423.10M
|
Composite
37.0
Moat
47.9
|
0.15
No YoY
|
1.7%
-4.8
YoY
|
|
|
422.03M
|
Composite
51.2
Moat
-
|
20.62
-2.8
YoY
|
-20.3%
+35.7
YoY
|
|
|
420.80M
|
Composite
37.0
Moat
-
|
57.97
+35.8
YoY
|
-10.2%
+12.0
YoY
|
|
|
419.10M
|
Composite
44.4
Moat
-
|
21.30
-1.7
YoY
|
-
No YoY
|
|
|
417.79M
|
Composite
58.5
Moat
-
|
112.8
+101.7
YoY
|
-
No YoY
|
|
|
415.53M
|
Composite
46.9
Moat
-
|
31.11
-0.0
YoY
|
-
No YoY
|
|
|
IVVD
Invivyd, Inc.
|
412.89M
|
Composite
61.1
Moat
42.9
|
4.88
-9.0
YoY
|
-7.0%
No YoY
|
|
408.70M
|
Composite
52.5
Moat
-
|
46.44
No YoY
|
-79.4%
-86.1
YoY
|
|
|
402.50M
|
Composite
59.3
Moat
-
|
-
No YoY
|
16.4%
-8.2
YoY
|
|
|
398.23M
|
Composite
44.4
Moat
-
|
9.36
-4.8
YoY
|
-55.3%
No YoY
|
|
|
393.13M
|
Composite
46.5
Moat
-
|
17.42
+11.5
YoY
|
-23.8%
-12.6
YoY
|
|
|
SRZN
Surrozen, Inc.
|
392.04M
|
Composite
33.0
Moat
-
|
23.53
+12.8
YoY
|
-2.4%
+1.2
YoY
|
|
391.20M
|
Composite
66.1
Moat
-
|
34.20
+21.7
YoY
|
-33.4%
-14.9
YoY
|
|
|
390.40M
|
Composite
37.6
Moat
-
|
24.50
-7.4
YoY
|
-1.1%
+76.2
YoY
|
|
|
386.30M
|
Composite
30.3
Moat
-
|
141.2
+126.0
YoY
|
-16.9%
-6.4
YoY
|
|
|
TBRG
TruBridge, Inc.
|
383.60M
|
Composite
58.9
Moat
-
|
-
No YoY
|
1.9%
+4.3
YoY
|
|
379.00M
|
Composite
66.1
Moat
-
|
61.47
No YoY
|
16.3%
+2.9
YoY
|
|
|
375.59M
|
Composite
23.6
Moat
28.4
|
22.46
-4.9
YoY
|
-15.3%
+3.3
YoY
|
|
|
375.58M
|
Composite
45.5
Moat
49.5
|
14.23
-530.9
YoY
|
-3.1%
+52.4
YoY
|
|
|
AUNA
Auna SA
|
375.25M
|
Composite
51.5
Moat
-
|
-
No YoY
|
17.0%
+2.9
YoY
|
|
366.60M
|
Composite
44.6
Moat
-
|
11.38
-16.4
YoY
|
-109.3%
+41.9
YoY
|
|
|
365.99M
|
Composite
49.4
Moat
-
|
26.35
-13.9
YoY
|
-
No YoY
|
|
|
SOPH
SOPHiA GENETICS SA
|
359.78M
|
Composite
32.9
Moat
-
|
22.48
-8.0
YoY
|
-1.0%
+0.2
YoY
|
|
356.20M
|
Composite
46.1
Moat
-
|
24.84
+9.9
YoY
|
-2.3%
+0.5
YoY
|
|
|
353.10M
|
Composite
59.8
Moat
61.7
|
-
No YoY
|
7.1%
-1.0
YoY
|
|
|
351.90M
|
Composite
52.8
Moat
-
|
24.00
-9.9
YoY
|
-
No YoY
|
|
|
348.00M
|
Composite
39.4
Moat
-
|
0.46
-0.0
YoY
|
-48.1%
-19.4
YoY
|
|
|
347.64M
|
Composite
47.3
Moat
56.7
|
26.14
+9.4
YoY
|
-1.5%
+0.6
YoY
|
|
|
346.50M
|
Composite
44.9
Moat
-
|
26.96
+6.7
YoY
|
-62.9%
+30.8
YoY
|
|
|
342.61M
|
Composite
44.9
Moat
-
|
61.13
+52.3
YoY
|
-
No YoY
|
|
|
340.87M
|
Composite
48.6
Moat
-
|
64.07
-40.1
YoY
|
-5.9%
+1.1
YoY
|
|
|
336.70M
|
Composite
40.4
Moat
-
|
-
No YoY
|
50.4%
-9.3
YoY
|
|
|
335.78M
|
Composite
62.1
Moat
-
|
7.89
-13.1
YoY
|
-163.3%
-147.0
YoY
|
|
|
335.76M
|
Composite
33.0
Moat
-
|
2.97
-0.5
YoY
|
-
No YoY
|
|
|
PALI
Palisade Bio, Inc.
|
333.17M
|
Composite
41.5
Moat
-
|
9.67
-3.7
YoY
|
-51.4%
No YoY
|
|
329.20M
|
Composite
60.0
Moat
-
|
20.93
+4.0
YoY
|
-13.8%
+18.2
YoY
|
|
|
325.96M
|
Composite
50.9
Moat
-
|
33.90
-11.1
YoY
|
-66.6%
No YoY
|
|
|
324.50M
|
Composite
54.0
Moat
-
|
-
No YoY
|
8.2%
-0.6
YoY
|
|
|
323.02M
|
Composite
61.8
Moat
-
|
-
No YoY
|
7.9%
+3.5
YoY
|
|
|
319.49M
|
Composite
40.8
Moat
-
|
6.76
-6.2
YoY
|
-
No YoY
|
|
|
316.10M
|
Composite
54.9
Moat
-
|
15.31
-6.7
YoY
|
10.0%
+41.4
YoY
|
|
|
311.20M
|
Composite
27.9
Moat
-
|
113.8
+93.2
YoY
|
-7.6%
+32.5
YoY
|
|
|
309.50M
|
Composite
61.2
Moat
-
|
31.53
-20.0
YoY
|
-
No YoY
|
|
|
306.24M
|
Composite
43.9
Moat
-
|
40.43
+21.0
YoY
|
-268.1%
-176.5
YoY
|
|
|
303.59M
|
Composite
39.0
Moat
-
|
176.3
+134.0
YoY
|
-0.9%
+0.5
YoY
|
|
|
303.51M
|
Composite
56.3
Moat
-
|
42.23
+29.2
YoY
|
-69.9%
No YoY
|
|
|
302.90M
|
Composite
40.4
Moat
43.6
|
555.6
+388.6
YoY
|
-5.8%
-1.7
YoY
|
|
|
ACIU
AC Immune SA
|
302.20M
|
Composite
42.6
Moat
-
|
20.47
+0.5
YoY
|
-1.9%
+1.7
YoY
|
|
MASS
908 Devices Inc.
|
302.03M
|
Composite
44.5
Moat
-
|
27.61
-42.1
YoY
|
-82.6%
+2.3
YoY
|
|
RZLT
Rezolute, Inc.
|
300.50M
|
Composite
54.0
Moat
-
|
29.16
+2.6
YoY
|
-
No YoY
|
|
300.04M
|
Composite
53.5
Moat
-
|
26.06
-1.8
YoY
|
-2.8%
No YoY
|
|
|
296.70M
|
Composite
51.8
Moat
-
|
15.40
-13.9
YoY
|
-7.4%
-5.2
YoY
|
|
|
295.67M
|
Composite
53.0
Moat
-
|
57.07
+36.1
YoY
|
-
No YoY
|
|
|
293.23M
|
Composite
43.3
Moat
-
|
35.58
+20.1
YoY
|
-
No YoY
|
|
|
SGHT
Sight Sciences, Inc.
|
287.79M
|
Composite
47.8
Moat
-
|
64.62
+29.5
YoY
|
-63.3%
+7.4
YoY
|
|
285.90M
|
Composite
50.0
Moat
-
|
45.10
+16.6
YoY
|
-3.3%
+3.4
YoY
|
|
|
285.40M
|
Composite
46.0
Moat
-
|
13.11
-20.1
YoY
|
-
No YoY
|
|
|
282.50M
|
Composite
44.0
Moat
-
|
23.04
-4.2
YoY
|
-22.2%
-7.9
YoY
|
|
|
RXST
RxSight, Inc.
|
279.79M
|
Composite
42.5
Moat
-
|
168.0
+131.3
YoY
|
-35.8%
-9.5
YoY
|
|
CLLS
Cellectis S.A.
|
279.20M
|
Composite
60.0
Moat
-
|
98.84
+85.4
YoY
|
-1.4%
+127.4
YoY
|
|
275.79M
|
Composite
46.2
Moat
-
|
30.20
+3.0
YoY
|
-
No YoY
|
|
|
273.91M
|
Composite
35.0
Moat
-
|
2.50
-0.3
YoY
|
-1.2%
+1.7
YoY
|
|
|
ALEC
Alector, Inc.
|
270.90M
|
Composite
45.0
Moat
-
|
21.58
-14.2
YoY
|
-7.4%
-6.0
YoY
|
|
267.57M
|
Composite
31.6
Moat
-
|
26.11
-37.3
YoY
|
-40.5%
-38.8
YoY
|
|
|
267.05M
|
Composite
61.4
Moat
-
|
7.26
-19.8
YoY
|
-
No YoY
|
|
|
265.26M
|
Composite
59.3
Moat
-
|
23.71
+5.6
YoY
|
-
No YoY
|
|
|
262.30M
|
Composite
43.8
Moat
-
|
73.97
+65.9
YoY
|
-41.8%
+37.2
YoY
|
|
|
262.00M
|
Composite
37.0
Moat
-
|
28.10
+14.2
YoY
|
-3.1%
+0.9
YoY
|
|
|
CGEN
Compugen Ltd.
|
261.00M
|
Composite
56.0
Moat
-
|
16.95
-12.4
YoY
|
-53.4%
-14.6
YoY
|
|
255.60M
|
Composite
46.3
Moat
-
|
13.84
+6.2
YoY
|
-
No YoY
|
|
|
253.00M
|
Composite
58.3
Moat
-
|
47.61
-146.0
YoY
|
-69.1%
-19.5
YoY
|
|
|
LFMD
LifeMD, Inc.
|
252.80M
|
Composite
42.6
Moat
-
|
2.07
-12.9
YoY
|
-7.6%
+1.9
YoY
|
|
251.85M
|
Composite
27.9
Moat
-
|
-
No YoY
|
-1.0%
-5.7
YoY
|
|
|
251.63M
|
Composite
46.6
Moat
-
|
12.58
-4.2
YoY
|
-
No YoY
|
|
|
247.50M
|
Composite
57.5
Moat
-
|
9.29
-6.5
YoY
|
5.2%
+66.6
YoY
|
|
|
247.00M
|
Composite
55.9
Moat
70.0
|
31.58
+15.2
YoY
|
-8.0%
+79.1
YoY
|
|
|
246.54M
|
Composite
57.8
Moat
-
|
29.13
+5.4
YoY
|
-4.4%
-1.3
YoY
|
|
|
241.62M
|
Composite
51.6
Moat
-
|
28.99
+11.9
YoY
|
-61.1%
-49.2
YoY
|
|
|
HUMA
Humacyte, Inc.
|
239.78M
|
Composite
51.2
Moat
-
|
5.50
-7.7
YoY
|
-
No YoY
|
|
239.75M
|
Composite
39.6
Moat
-
|
107.8
+89.7
YoY
|
-93.3%
-90.0
YoY
|
|
|
ADAG
Adagene Inc.
|
238.52M
|
Composite
39.3
Moat
-
|
34.42
-11.9
YoY
|
-348.4%
-347.0
YoY
|
|
236.00M
|
Composite
49.6
Moat
-
|
209.0
+95.0
YoY
|
-1.0%
-49.8
YoY
|
|
|
CDXS
Codexis, Inc.
|
234.40M
|
Composite
47.3
Moat
-
|
17.84
+3.0
YoY
|
-98.3%
-20.2
YoY
|
|
233.10M
|
Composite
69.6
Moat
-
|
41.77
+9.9
YoY
|
-59.0%
+1050.5
YoY
|
|
|
229.99M
|
Composite
45.7
Moat
-
|
15.86
-6.9
YoY
|
-24.4%
-5.7
YoY
|
|
|
SPOK
Spok Holdings, Inc.
|
226.20M
|
Composite
61.9
Moat
-
|
-
No YoY
|
14.1%
-0.5
YoY
|
|
225.36M
|
Composite
53.2
Moat
-
|
16.87
+6.4
YoY
|
-81.4%
+66.8
YoY
|
|
|
NKTX
Nkarta, Inc.
|
224.57M
|
Composite
55.3
Moat
-
|
32.18
-2.4
YoY
|
-
No YoY
|
|
MDWD
MediWound Ltd.
|
221.96M
|
Composite
65.0
Moat
-
|
8.06
-5.5
YoY
|
-95.9%
-12.9
YoY
|
|
HITI
High Tide Inc.
|
219.39M
|
Composite
46.2
Moat
-
|
-
No YoY
|
2.6%
-0.3
YoY
|
|
ELMD
Electromed, Inc.
|
214.70M
|
Composite
66.1
Moat
-
|
142.6
No YoY
|
15.1%
+3.1
YoY
|
|
214.08M
|
Composite
51.7
Moat
-
|
77.85
+69.6
YoY
|
-
No YoY
|
|
|
EMBC
Embecta Corp.
|
213.58M
|
Composite
55.0
Moat
-
|
-
No YoY
|
27.4%
+2.0
YoY
|
|
212.17M
|
Composite
39.6
Moat
-
|
28.65
-4.2
YoY
|
-35.5%
+67.2
YoY
|
|
|
208.90M
|
Composite
39.4
Moat
-
|
14.80
-3.9
YoY
|
-3.3%
+0.0
YoY
|
|
|
208.30M
|
Composite
60.2
Moat
-
|
-
No YoY
|
29.6%
-3.6
YoY
|
|
|
207.40M
|
Composite
28.0
Moat
-
|
28.18
-23.7
YoY
|
-59.2%
-46.4
YoY
|
|
|
OABI
OmniAb, Inc.
|
207.04M
|
Composite
55.2
Moat
-
|
17.98
-277.3
YoY
|
-2.8%
-0.8
YoY
|
|
205.18M
|
Composite
45.3
Moat
-
|
10.98
+4.6
YoY
|
-30.8%
-11.8
YoY
|
|
|
205.00M
|
Composite
58.6
Moat
-
|
-
No YoY
|
8.3%
+3.2
YoY
|
|
|
203.76M
|
Composite
40.7
Moat
-
|
6.08
-0.8
YoY
|
-10.6%
+9.4
YoY
|
|
|
203.09M
|
Composite
42.0
Moat
41.8
|
59.89
-0.1
YoY
|
-39.8%
-5.0
YoY
|
|
|
201.40M
|
Composite
52.1
Moat
-
|
461.3
No YoY
|
-4.2%
-5.0
YoY
|
|
|
200.80M
|
Composite
52.8
Moat
-
|
24.55
-23.2
YoY
|
2.9%
+14.4
YoY
|
|
|
THAR
Tharimmune, Inc.
|
198.86M
|
Composite
41.9
Moat
-
|
3.92
-14.1
YoY
|
-
No YoY
|
|
TKNO
Alpha Teknova, Inc.
|
195.14M
|
Composite
36.3
Moat
-
|
29.44
+11.3
YoY
|
-41.9%
+27.4
YoY
|
|
193.70M
|
Composite
45.8
Moat
-
|
42.80
+35.8
YoY
|
-63.5%
No YoY
|
|
|
193.70M
|
Composite
47.6
Moat
-
|
20.67
-5.0
YoY
|
-1.0%
+17.8
YoY
|
|
|
INGN
Inogen, Inc
|
193.60M
|
Composite
47.5
Moat
-
|
476.7
+416.9
YoY
|
-8.7%
+4.0
YoY
|
|
193.59M
|
Composite
54.8
Moat
-
|
21.68
+7.7
YoY
|
-
No YoY
|
|
|
193.48M
|
Composite
51.3
Moat
-
|
19.46
+16.5
YoY
|
-7.4%
+7.8
YoY
|
|
|
193.01M
|
Composite
38.4
Moat
-
|
17.72
+1.1
YoY
|
-38.1%
+51.7
YoY
|
|
|
KRRO
Korro Bio, Inc.
|
192.40M
|
Composite
49.8
Moat
-
|
25.19
-4.4
YoY
|
-40.5%
No YoY
|
|
187.80M
|
Composite
52.2
Moat
40.3
|
45.88
+13.2
YoY
|
-5.9%
+15.8
YoY
|
|
|
187.61M
|
Composite
43.3
Moat
-
|
29.28
+28.4
YoY
|
-
No YoY
|
|
|
MGNX
MacroGenics, Inc.
|
186.90M
|
Composite
59.2
Moat
-
|
35.39
+0.1
YoY
|
-74.5%
-71.6
YoY
|
|
CVRX
CVRx, Inc.
|
186.87M
|
Composite
36.8
Moat
-
|
22.62
-9.9
YoY
|
-90.5%
-89.3
YoY
|
|
STXS
Stereotaxis, Inc.
|
186.70M
|
Composite
32.0
Moat
-
|
17.25
-8.8
YoY
|
-91.9%
-10.3
YoY
|
|
185.90M
|
Composite
46.7
Moat
-
|
359.6
+331.4
YoY
|
-19.2%
+16.8
YoY
|
|
|
185.90M
|
Composite
39.2
Moat
-
|
481.5
+468.3
YoY
|
-9.3%
-3.7
YoY
|
|
|
184.73M
|
Composite
50.6
Moat
-
|
18.19
-24.1
YoY
|
-16.7%
-13.3
YoY
|
|
|
184.14M
|
Composite
47.7
Moat
-
|
5.70
+1.0
YoY
|
-
No YoY
|
|
|
184.10M
|
Composite
52.3
Moat
-
|
8.15
-4.2
YoY
|
-
No YoY
|
|
|
PDEX
Pro-Dex, Inc.
|
183.30M
|
Composite
55.4
Moat
-
|
51.07
+28.3
YoY
|
16.1%
+2.7
YoY
|
|
IFRX
InflaRx N.V.
|
180.70M
|
Composite
41.1
Moat
-
|
13.06
-15.6
YoY
|
-319.7%
+392.1
YoY
|
|
179.67M
|
Composite
53.0
Moat
-
|
13.87
+7.1
YoY
|
-2.3%
+9.0
YoY
|
|
|
178.40M
|
Composite
42.0
Moat
-
|
23.88
-44.0
YoY
|
-
No YoY
|
|
|
SMTI
Sanara MedTech Inc.
|
175.50M
|
Composite
39.4
Moat
-
|
8011.2
+7992.2
YoY
|
-10.0%
+1.8
YoY
|
|
174.86M
|
Composite
45.2
Moat
-
|
67.61
+38.8
YoY
|
-62.5%
-61.3
YoY
|
|
|
HYPR
Hyperfine, Inc.
|
170.44M
|
Composite
35.7
Moat
-
|
11.65
-9.9
YoY
|
-3.4%
+1.0
YoY
|
|
166.50M
|
Composite
56.0
Moat
-
|
49.26
+32.7
YoY
|
-1.6%
+3.7
YoY
|
|
|
165.58M
|
Composite
49.9
Moat
-
|
20.37
-3.8
YoY
|
-
No YoY
|
|
|
165.50M
|
Composite
38.0
Moat
-
|
10.23
-14.5
YoY
|
-62.1%
+20.1
YoY
|
|
|
161.90M
|
Composite
59.0
Moat
-
|
-
No YoY
|
-0.8%
-2.2
YoY
|
|
|
161.55M
|
Composite
59.8
Moat
-
|
18.99
-4.6
YoY
|
-
No YoY
|
|
|
159.97M
|
Composite
44.9
Moat
-
|
26.00
+15.6
YoY
|
-
No YoY
|
|
|
IMUX
Immunic, Inc.
|
159.80M
|
Composite
36.1
Moat
-
|
5.05
-2.9
YoY
|
-
No YoY
|
|
159.50M
|
Composite
61.8
Moat
-
|
405.7
+395.1
YoY
|
7.3%
-8.6
YoY
|
|
|
158.50M
|
Composite
68.0
Moat
-
|
202.5
+13.6
YoY
|
-11.8%
+3.3
YoY
|
|
|
157.48M
|
Composite
47.4
Moat
-
|
30.27
-7.7
YoY
|
-12.3%
-3.6
YoY
|
|
|
BDSX
Biodesix, Inc.
|
156.36M
|
Composite
28.9
Moat
-
|
6.47
-7.3
YoY
|
-31.5%
+16.5
YoY
|
|
EDAP
EDAP TMS S.A.
|
155.70M
|
Composite
32.0
Moat
-
|
26.36
-9.2
YoY
|
-32.0%
+0.8
YoY
|
|
EDSA
Edesa Biotech, Inc.
|
154.88M
|
Composite
53.4
Moat
-
|
17.69
+15.1
YoY
|
-47362.7%
No YoY
|
|
154.40M
|
Composite
38.4
Moat
-
|
98.67
-105.9
YoY
|
-38.9%
-2.0
YoY
|
|
|
152.87M
|
Composite
38.3
Moat
-
|
8.31
-26.4
YoY
|
-11.4%
-6.3
YoY
|
|
|
152.59M
|
Composite
42.6
Moat
-
|
10.31
+6.6
YoY
|
-
No YoY
|
|
|
149.47M
|
Composite
30.4
Moat
-
|
10.77
-3.9
YoY
|
-490.9%
No YoY
|
|
|
148.10M
|
Composite
38.5
Moat
-
|
4.34
-5.0
YoY
|
-
No YoY
|
|
|
147.10M
|
Composite
34.8
Moat
-
|
7.44
-1.5
YoY
|
-
No YoY
|
|
|
145.30M
|
Composite
56.5
Moat
-
|
27.07
-0.7
YoY
|
-2.6%
-30.3
YoY
|
|
|
144.82M
|
Composite
57.0
Moat
-
|
9.12
-12.5
YoY
|
-8.7%
+3.6
YoY
|
|
|
AGEN
Agenus Inc.
|
144.00M
|
Composite
44.6
Moat
-
|
3.07
-1.0
YoY
|
-1.2%
-0.2
YoY
|
|
143.10M
|
Composite
59.7
Moat
-
|
-
No YoY
|
-15.0%
-25.6
YoY
|
|
|
PYXS
Pyxis Oncology, Inc.
|
142.00M
|
Composite
49.4
Moat
-
|
26.41
+6.2
YoY
|
-4.2%
No YoY
|
|
140.17M
|
Composite
43.3
Moat
-
|
47.62
+17.9
YoY
|
-86.2%
No YoY
|
|
|
IPHA
Innate Pharma S.A.
|
139.82M
|
Composite
42.7
Moat
-
|
140.6
+106.5
YoY
|
-4.1%
+20.3
YoY
|
|
NYXH
Nyxoah SA
|
139.32M
|
Composite
26.1
Moat
-
|
20.86
+5.4
YoY
|
-13.0%
-2.6
YoY
|
|
ACOG
Alpha Cognition Inc.
|
138.92M
|
Composite
55.0
Moat
-
|
75.11
+73.2
YoY
|
-
No YoY
|
|
137.20M
|
Composite
53.7
Moat
72.1
|
14.24
-8.3
YoY
|
-20.1%
+20.1
YoY
|
|
|
OWLT
Owlet, Inc.
|
136.86M
|
Composite
53.2
Moat
-
|
21.67
+13.2
YoY
|
-25.9%
+27.1
YoY
|
|
136.65M
|
Composite
47.0
Moat
-
|
26.70
-1.7
YoY
|
-32.5%
-33.8
YoY
|
|
|
136.00M
|
Composite
37.2
Moat
38.2
|
-
No YoY
|
-92.9%
-89.0
YoY
|
|
|
RCEL
Avita Medical, Inc.
|
135.40M
|
Composite
32.2
Moat
-
|
7.00
-1.8
YoY
|
-59.4%
+28.7
YoY
|
|
129.49M
|
Composite
32.1
Moat
-
|
33.17
+11.7
YoY
|
-42.2%
+43.3
YoY
|
|
|
128.50M
|
Composite
67.9
Moat
-
|
-
No YoY
|
-4.9%
-2.4
YoY
|
|
|
STIM
Neuronetics, Inc.
|
128.04M
|
Composite
40.1
Moat
-
|
7.23
-15.5
YoY
|
-46.2%
-3.3
YoY
|
|
CCLD
CareCloud, Inc.
|
127.10M
|
Composite
63.3
Moat
-
|
-
No YoY
|
8.8%
+12.2
YoY
|
|
GNLX
Genelux Corporation
|
125.57M
|
Composite
45.2
Moat
-
|
17.46
+3.7
YoY
|
-3962.0%
-3819.9
YoY
|
|
124.40M
|
Composite
60.0
Moat
-
|
22.96
No YoY
|
-6.8%
+17.8
YoY
|
|
|
JYNT
The Joint Corp.
|
124.20M
|
Composite
54.2
Moat
-
|
-
No YoY
|
-3.5%
-4.1
YoY
|
|
124.07M
|
Composite
38.5
Moat
-
|
24.43
-18.3
YoY
|
-25.5%
+1.1
YoY
|
|
|
PEPG
PepGen Inc.
|
123.81M
|
Composite
56.4
Moat
-
|
17.51
-1.7
YoY
|
-
No YoY
|
|
FONR
Fonar Corporation
|
123.80M
|
Composite
52.8
Moat
-
|
-
No YoY
|
11.1%
-5.0
YoY
|
|
NNOX
NANO-X IMAGING LTD
|
122.48M
|
Composite
41.4
Moat
-
|
24.00
+1.9
YoY
|
-5.0%
+1.0
YoY
|
|
122.20M
|
Composite
30.2
Moat
-
|
1.18
-4.8
YoY
|
-26.7%
-7.6
YoY
|
|
|
122.10M
|
Composite
47.7
Moat
-
|
21.11
-78.7
YoY
|
-39.2%
-1.1
YoY
|
|
|
119.04M
|
Composite
28.6
Moat
-
|
1.36
-0.4
YoY
|
-4.9%
-4.0
YoY
|
|
|
BMEA
Biomea Fusion, Inc.
|
117.85M
|
Composite
52.0
Moat
-
|
5.83
-16.1
YoY
|
-
No YoY
|
|
117.16M
|
Composite
33.9
Moat
-
|
13.79
-10.7
YoY
|
-1.8%
+0.7
YoY
|
|
|
GUTS
Fractyl Health, Inc.
|
116.64M
|
Composite
32.7
Moat
-
|
12.36
+3.1
YoY
|
-1005.7%
-582.1
YoY
|
|
HCAT
Health Catalyst, Inc
|
115.53M
|
Composite
36.3
Moat
42.1
|
115.3
-8.4
YoY
|
-22.8%
+20.1
YoY
|
|
110.60M
|
Composite
49.1
Moat
-
|
7.42
-7.1
YoY
|
-4.5%
+5.0
YoY
|
|
|
CBUS
Cibus, Inc.
|
110.00M
|
Composite
42.3
Moat
-
|
2.98
-5.5
YoY
|
-18.1%
+20.2
YoY
|
|
109.40M
|
Composite
42.1
Moat
-
|
29.21
+0.1
YoY
|
-82.6%
-11.3
YoY
|
|
|
KALA
KALA BIO, Inc.
|
106.90M
|
Composite
34.7
Moat
-
|
20.90
-1.0
YoY
|
-20.9%
-11.2
YoY
|
|
SEER
Seer, Inc.
|
106.07M
|
Composite
53.7
Moat
-
|
61.53
-2.7
YoY
|
-4.7%
+2.5
YoY
|
|
104.70M
|
Composite
51.1
Moat
-
|
28.09
-28.4
YoY
|
-
No YoY
|
|
|
104.50M
|
Composite
43.6
Moat
-
|
7.09
-7.6
YoY
|
-
No YoY
|
|
|
103.65M
|
Composite
53.0
Moat
-
|
10.54
-11.9
YoY
|
-
No YoY
|
|
|
MDXH
MDxHealth SA
|
103.24M
|
Composite
42.5
Moat
-
|
30.31
+17.8
YoY
|
-26.7%
+11.4
YoY
|
|
VANI
Vivani Medical, Inc.
|
102.42M
|
Composite
47.8
Moat
-
|
10.59
+0.1
YoY
|
-
No YoY
|
|
ATYR
aTyr Pharma, Inc.
|
102.00M
|
Composite
42.4
Moat
-
|
12.52
-22.9
YoY
|
-289.0%
-133.4
YoY
|
|
NRXS
Neuraxis, Inc.
|
101.36M
|
Composite
52.5
Moat
-
|
7.27
+7.1
YoY
|
-2.7%
+0.0
YoY
|
|
101.20M
|
Composite
39.8
Moat
-
|
1.63
-0.9
YoY
|
-
No YoY
|
|
|
99.46M
|
Composite
61.5
Moat
-
|
44.72
+9.7
YoY
|
-4.9%
-3.5
YoY
|
|
|
99.20M
|
Composite
40.4
Moat
-
|
25.39
-7.2
YoY
|
-52.4%
-26.8
YoY
|
|
|
98.64M
|
Composite
49.2
Moat
-
|
5.88
-8.1
YoY
|
-
No YoY
|
|
|
95.83M
|
Composite
41.1
Moat
-
|
9.34
-2.0
YoY
|
-48.2%
-29.3
YoY
|
|
|
94.70M
|
Composite
32.7
Moat
-
|
10.85
-3.2
YoY
|
-516.2%
-355.8
YoY
|
|
|
QTTB
Q32 Bio Inc.
|
92.24M
|
Composite
52.1
Moat
-
|
13.82
-2.6
YoY
|
7.3%
+13.2
YoY
|
|
MXCT
MaxCyte, Inc.
|
90.48M
|
Composite
44.4
Moat
-
|
67.14
-26.0
YoY
|
-1.3%
-0.2
YoY
|
|
ACET
Adicet Bio, Inc.
|
89.43M
|
Composite
41.8
Moat
-
|
22.90
+2.5
YoY
|
-2.9%
+3.4
YoY
|
|
OKYO
OKYO Pharma Limited
|
88.17M
|
Composite
49.3
Moat
-
|
10.34
+9.3
YoY
|
-
No YoY
|
|
PYPD
PolyPid Ltd.
|
85.49M
|
Composite
44.5
Moat
-
|
8.55
+4.8
YoY
|
-
No YoY
|
|
EXOZ
eXoZymes, Inc.
|
84.79M
|
Composite
49.7
Moat
-
|
13.71
+13.0
YoY
|
-
No YoY
|
|
83.57M
|
Composite
38.5
Moat
30.7
|
43.76
+27.4
YoY
|
-55.8%
+43.9
YoY
|
|
|
83.00M
|
Composite
61.0
Moat
-
|
5.12
No YoY
|
8.5%
+22.3
YoY
|
|
|
ANVS
Annovis Bio, Inc.
|
82.88M
|
Composite
45.3
Moat
-
|
5.78
+4.1
YoY
|
-
No YoY
|
|
82.10M
|
Composite
65.1
Moat
-
|
8.57
+1.0
YoY
|
-1.9%
-0.3
YoY
|
|
|
81.90M
|
Composite
45.5
Moat
-
|
42.61
+30.6
YoY
|
-3.5%
No YoY
|
|
|
81.47M
|
Composite
45.9
Moat
-
|
6.60
-4.1
YoY
|
-403.3%
-276.4
YoY
|
|
|
80.98M
|
Composite
50.5
Moat
-
|
32.80
-3.1
YoY
|
-
No YoY
|
|
|
80.80M
|
Composite
58.9
Moat
-
|
6.25
-1.0
YoY
|
-10.3%
+0.8
YoY
|
|
|
GOSS
Gossamer Bio, Inc.
|
80.67M
|
Composite
44.5
Moat
-
|
1019.1
+996.7
YoY
|
-52.2%
No YoY
|
|
79.53M
|
Composite
40.1
Moat
-
|
8.58
No YoY
|
-
No YoY
|
|
|
79.48M
|
Composite
40.3
Moat
-
|
7.34
+0.8
YoY
|
-
No YoY
|
|
|
XBIT
XBiotech Inc.
|
77.70M
|
Composite
53.3
Moat
-
|
66.92
-61.3
YoY
|
-8.6%
-7.2
YoY
|
|
77.33M
|
Composite
52.0
Moat
-
|
39.65
-4.1
YoY
|
-
No YoY
|
|
|
RLYB
Rallybio Corporation
|
77.02M
|
Composite
64.5
Moat
-
|
15.95
-5.9
YoY
|
-95.1%
No YoY
|
|
ICCC
ImmuCell Corporation
|
76.63M
|
Composite
58.9
Moat
-
|
2.51
-42.5
YoY
|
-6.2%
+26.7
YoY
|
|
76.40M
|
Composite
60.7
Moat
-
|
7.82
-1.0
YoY
|
-63.5%
-52.8
YoY
|
|
|
76.16M
|
Composite
46.2
Moat
-
|
27.45
-23.5
YoY
|
-116.5%
-103.4
YoY
|
|
|
SCYX
SCYNEXIS, Inc.
|
76.05M
|
Composite
38.7
Moat
-
|
29.64
+18.6
YoY
|
-9.9%
-61.8
YoY
|
|
75.18M
|
Composite
41.3
Moat
-
|
39.10
+17.4
YoY
|
-475.8%
-345.6
YoY
|
|
|
75.13M
|
Composite
47.3
Moat
-
|
31.41
-6.1
YoY
|
-47.9%
-43.4
YoY
|
|
|
74.80M
|
Composite
49.3
Moat
-
|
2.49
-10.6
YoY
|
-44.5%
No YoY
|
|
|
72.69M
|
Composite
27.6
Moat
-
|
1.50
-2.8
YoY
|
-
No YoY
|
|
|
71.98M
|
Composite
65.5
Moat
-
|
8.57
+1.0
YoY
|
-1.9%
-0.3
YoY
|
|
|
71.47M
|
Composite
47.8
Moat
-
|
9.12
+9.0
YoY
|
-
No YoY
|
|
|
XGN
Exagen Inc.
|
70.98M
|
Composite
40.8
Moat
37.5
|
19.91
-10.4
YoY
|
-24.5%
+18.9
YoY
|
|
ZTEK
Zentek Ltd.
|
70.90M
|
Composite
29.9
Moat
-
|
0.23
-5.0
YoY
|
-11.0%
+390.7
YoY
|
|
70.90M
|
Composite
50.3
Moat
-
|
4.75
+3.1
YoY
|
-
No YoY
|
|
|
MDAI
Spectral AI, Inc.
|
70.65M
|
Composite
38.2
Moat
-
|
6.73
+2.4
YoY
|
-22.2%
+49.7
YoY
|
|
MNOV
MediciNova, Inc.
|
70.40M
|
Composite
42.7
Moat
-
|
45.51
-36.9
YoY
|
-32.4%
-22.5
YoY
|
|
69.60M
|
Composite
55.9
Moat
-
|
13.20
-4.5
YoY
|
-
No YoY
|
|
|
69.45M
|
Composite
50.4
Moat
-
|
0.96
-1.5
YoY
|
-187.3%
No YoY
|
|
|
68.61M
|
Composite
38.3
Moat
-
|
4.44
-20.3
YoY
|
-276.6%
+1274.0
YoY
|
|
|
67.61M
|
Composite
39.4
Moat
-
|
6.12
+6.1
YoY
|
-68.1%
0.0
YoY
|
|
|
67.30M
|
Composite
49.8
Moat
-
|
318.5
+189.0
YoY
|
-37.5%
-56.9
YoY
|
|
|
FORA
Forian Inc.
|
67.17M
|
Composite
56.5
Moat
-
|
28.24
+6.6
YoY
|
-27.6%
-12.0
YoY
|
|
BTMD
Biote Corp.
|
66.98M
|
Composite
51.4
Moat
-
|
103.8
No YoY
|
16.0%
+0.6
YoY
|
|
LNSR
LENSAR, Inc.
|
65.13M
|
Composite
38.5
Moat
34.4
|
118.4
+88.5
YoY
|
-13.0%
+16.0
YoY
|
|
64.20M
|
Composite
45.0
Moat
-
|
352.1
No YoY
|
-17.0%
+7.2
YoY
|
|
|
CING
Cingulate Inc.
|
64.07M
|
Composite
46.9
Moat
-
|
7.94
+7.9
YoY
|
-
No YoY
|
|
BYSI
BeyondSpring, Inc.
|
63.70M
|
Composite
52.0
Moat
-
|
2.13
-1.8
YoY
|
-27.6%
+21.5
YoY
|
|
IMMP
Immutep Limited
|
63.70M
|
Composite
42.7
Moat
-
|
62.68
+21.4
YoY
|
-25.1%
+173.5
YoY
|
|
DCGO
DocGo Inc.
|
62.60M
|
Composite
34.3
Moat
-
|
11.08
-1070.6
YoY
|
4.7%
+2.2
YoY
|
|
IBIO
iBio, Inc.
|
61.10M
|
Composite
45.7
Moat
-
|
6.73
-2.5
YoY
|
-46.5%
+27.4
YoY
|
|
59.16M
|
Composite
44.7
Moat
-
|
14.28
-5.9
YoY
|
-
No YoY
|
|
|
59.09M
|
Composite
45.9
Moat
56.5
|
-
No YoY
|
29.2%
+3.4
YoY
|
|
|
DRIO
DarioHealth Corp.
|
58.30M
|
Composite
31.1
Moat
-
|
8.86
-5.7
YoY
|
-2.1%
+0.6
YoY
|
|
ENTX
Entera Bio Ltd.
|
58.28M
|
Composite
49.3
Moat
-
|
15.24
-2.8
YoY
|
-53.0%
+44.2
YoY
|
|
57.30M
|
Composite
38.4
Moat
-
|
5.65
-12.1
YoY
|
41.3%
+1.1
YoY
|
|
|
56.55M
|
Composite
24.2
Moat
-
|
2.27
+1.0
YoY
|
-1.6%
+0.6
YoY
|
|
|
56.21M
|
Composite
48.7
Moat
-
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
55.67M
|
Composite
50.1
Moat
-
|
5.75
+3.2
YoY
|
-
No YoY
|
|
|
55.60M
|
Composite
37.4
Moat
-
|
7.49
+3.2
YoY
|
-1.7%
+65.8
YoY
|
|
|
55.46M
|
Composite
38.1
Moat
-
|
3.11
-19.2
YoY
|
-
No YoY
|
|
|
55.11M
|
Composite
38.9
Moat
-
|
20.27
+12.1
YoY
|
-
No YoY
|
|
|
54.52M
|
Composite
47.0
Moat
47.8
|
21.38
-8.2
YoY
|
-15.0%
No YoY
|
|
|
TIL
Instil Bio, Inc.
|
54.32M
|
Composite
52.0
Moat
-
|
24.41
+2.4
YoY
|
-
No YoY
|
|
NSPR
InspireMD Inc.
|
54.30M
|
Composite
38.6
Moat
-
|
19.01
-9.6
YoY
|
-4.8%
-1.4
YoY
|
|
BGM
BGM Group Ltd.
|
54.27M
|
Composite
50.5
Moat
49.6
|
-
No YoY
|
-1.4%
+3.8
YoY
|
|
PRPO
Precipio, Inc.
|
54.20M
|
Composite
50.1
Moat
-
|
5.06
-0.3
YoY
|
-22.8%
+27.4
YoY
|
|
MGX
Metagenomi, Inc.
|
53.46M
|
Composite
51.2
Moat
45.6
|
27.32
-8.3
YoY
|
-1.7%
+0.1
YoY
|
|
COCH
Envoy Medical, Inc.
|
51.94M
|
Composite
31.1
Moat
-
|
3.67
+0.7
YoY
|
-85.6%
-27.5
YoY
|
|
51.91M
|
Composite
28.4
Moat
-
|
6.00
+4.2
YoY
|
-29.1%
-14.8
YoY
|
|
|
51.10M
|
Composite
42.5
Moat
-
|
3.94
-7.8
YoY
|
-
No YoY
|
|
|
ECOR
electroCore, Inc.
|
50.68M
|
Composite
35.8
Moat
-
|
20.67
+12.2
YoY
|
-48.3%
-47.1
YoY
|
|
ONMD
OneMedNet Corp
|
50.16M
|
Composite
30.2
Moat
-
|
5.19
+5.1
YoY
|
-14.9%
-8.2
YoY
|
|
ATHA
Athira Pharma, Inc.
|
50.13M
|
Composite
40.9
Moat
-
|
6.33
-11.2
YoY
|
-
No YoY
|
|
49.90M
|
Composite
45.1
Moat
-
|
40.56
-10.1
YoY
|
-
No YoY
|
|
|
YI
111, Inc.
|
49.49M
|
Composite
35.0
Moat
42.5
|
17.54
-438.3
YoY
|
0.0%
+2.3
YoY
|
|
PETS
PetMed Express, Inc.
|
49.20M
|
Composite
21.9
Moat
-
|
-
No YoY
|
-3.0%
-5.4
YoY
|
|
INCR
Intercure Ltd.
|
47.51M
|
Composite
41.5
Moat
-
|
14.10
-8.6
YoY
|
-18.9%
-29.4
YoY
|
|
46.73M
|
Composite
55.1
Moat
33.1
|
36.10
+28.3
YoY
|
-9.4%
No YoY
|
|
|
BEAT
Heartbeam, Inc.
|
46.69M
|
Composite
29.4
Moat
-
|
1.97
-14.1
YoY
|
-
No YoY
|
|
46.33M
|
Composite
58.2
Moat
-
|
-
No YoY
|
8.8%
-0.4
YoY
|
|
|
NTRB
Nutriband Inc.
|
46.10M
|
Composite
40.2
Moat
-
|
11.18
+9.5
YoY
|
-3.1%
-0.8
YoY
|
|
46.00M
|
Composite
44.0
Moat
-
|
3.24
-19.8
YoY
|
-2396.9%
-2385.9
YoY
|
|
|
45.38M
|
Composite
54.0
Moat
-
|
3.00
+3.0
YoY
|
-
No YoY
|
|
|
ELUT
Elutia, Inc.
|
45.09M
|
Composite
38.9
Moat
-
|
7.01
-3.6
YoY
|
-99.6%
-16.6
YoY
|
|
PAVM
PAVmed Inc.
|
44.70M
|
Composite
28.3
Moat
-
|
0.42
-4.1
YoY
|
-14.8%
+13.2
YoY
|
|
TELA
TELA Bio, Inc.
|
44.29M
|
Composite
41.2
Moat
-
|
15.20
+1.5
YoY
|
-60.2%
+15.2
YoY
|
|
43.90M
|
Composite
51.1
Moat
-
|
1.00
-7.2
YoY
|
-50.8%
-11.6
YoY
|
|
|
TLPH
Talphera, Inc.
|
43.90M
|
Composite
38.7
Moat
-
|
8.39
+2.0
YoY
|
-25.9%
-13.2
YoY
|
|
MEIP
MEI Pharma, Inc.
|
43.30M
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
42.10M
|
Composite
49.0
Moat
-
|
7.42
+4.2
YoY
|
-64.7%
-32.5
YoY
|
|
|
42.02M
|
Composite
24.5
Moat
-
|
6.11
-6.1
YoY
|
-
No YoY
|
|
|
42.00M
|
Composite
28.6
Moat
-
|
7.91
-0.7
YoY
|
-1.0%
+57.3
YoY
|
|
|
41.20M
|
Composite
51.5
Moat
-
|
4.10
-3.9
YoY
|
-
No YoY
|
|
|
RNXT
RenovoRx, Inc.
|
40.09M
|
Composite
52.3
Moat
-
|
9.41
+8.0
YoY
|
-255.1%
No YoY
|
|
39.42M
|
Composite
38.2
Moat
-
|
8.46
-12.2
YoY
|
-22.6%
-16.9
YoY
|
|
|
38.31M
|
Composite
45.0
Moat
-
|
25.51
-7.1
YoY
|
-2.7%
+32.3
YoY
|
|
|
38.30M
|
Composite
45.4
Moat
-
|
26.45
+7.0
YoY
|
-641.0%
-607.9
YoY
|
|
|
INMB
INmune Bio Inc.
|
38.02M
|
Composite
50.4
Moat
-
|
7.53
-28.4
YoY
|
-3045.4%
-2853.5
YoY
|
|
36.80M
|
Composite
51.1
Moat
43.7
|
4.89
+3.2
YoY
|
0.3%
-4.0
YoY
|
|
|
EVAX
Evaxion Biotech A/S
|
36.78M
|
Composite
61.6
Moat
-
|
4.68
+1.8
YoY
|
-4.4%
+299.7
YoY
|
|
SNPX
Synaptogenix, Inc.
|
36.76M
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
NXTC
NextCure, Inc.
|
36.72M
|
Composite
48.5
Moat
-
|
20.18
-4.4
YoY
|
-
No YoY
|
|
36.70M
|
Composite
52.4
Moat
-
|
17.82
-4.6
YoY
|
-83.8%
No YoY
|
|
|
36.20M
|
Composite
42.6
Moat
-
|
27.79
+26.2
YoY
|
-46.5%
-43.0
YoY
|
|
|
35.70M
|
Composite
45.2
Moat
-
|
2.73
-5.1
YoY
|
-47.2%
-46.1
YoY
|
|
|
VERU
Veru Inc.
|
35.60M
|
Composite
52.4
Moat
-
|
7.32
-6.9
YoY
|
-5.9%
-3.7
YoY
|
|
BOLD
Boundless Bio, Inc.
|
35.42M
|
Composite
46.3
Moat
-
|
30.00
-0.9
YoY
|
-
No YoY
|
|
CRVO
CervoMed Inc.
|
35.18M
|
Composite
50.7
Moat
-
|
28.25
+15.7
YoY
|
-
No YoY
|
|
APLM
Apollomics Inc.
|
34.92M
|
Composite
38.2
Moat
-
|
4.08
-6.4
YoY
|
-
No YoY
|
|
ARAY
Accuray Incorporated
|
34.90M
|
Composite
43.4
Moat
-
|
69.12
-374.6
YoY
|
1.7%
+1.6
YoY
|
|
34.88M
|
Composite
46.0
Moat
-
|
20.11
-4.5
YoY
|
-
No YoY
|
|
|
NEPH
Nephros, Inc.
|
34.30M
|
Composite
58.9
Moat
-
|
91.71
+78.2
YoY
|
0.0%
+11.2
YoY
|
|
34.30M
|
Composite
40.4
Moat
-
|
73.24
No YoY
|
-2.7%
-3.6
YoY
|
|
|
33.81M
|
Composite
31.5
Moat
-
|
1.40
+0.6
YoY
|
-64.3%
-63.2
YoY
|
|
|
33.70M
|
Composite
41.2
Moat
45.0
|
1.44
-2.2
YoY
|
-6.7%
+0.2
YoY
|
|
|
33.60M
|
Composite
32.9
Moat
-
|
4.97
-0.1
YoY
|
-28.6%
+92.9
YoY
|
|
|
PLUR
Pluri Inc.
|
33.20M
|
Composite
38.9
Moat
-
|
13.58
-6.4
YoY
|
-16.6%
+51.4
YoY
|
|
MYO
Myomo Inc.
|
32.90M
|
Composite
39.6
Moat
-
|
90.70
+73.5
YoY
|
-19.1%
+23.7
YoY
|
|
32.80M
|
Composite
49.6
Moat
-
|
6.93
-3.6
YoY
|
-
No YoY
|
|
|
32.40M
|
Composite
31.3
Moat
-
|
13.39
-0.0
YoY
|
-78.3%
-6.0
YoY
|
|
|
31.90M
|
Composite
41.2
Moat
-
|
13.94
-1.3
YoY
|
0.6%
+8.6
YoY
|
|
|
31.74M
|
Composite
34.4
Moat
-
|
4.00
+0.2
YoY
|
-
No YoY
|
|
|
IGC
IGC Pharma, Inc.
|
31.40M
|
Composite
47.3
Moat
41.4
|
1.01
-1.8
YoY
|
-5.9%
+1.4
YoY
|
|
31.15M
|
Composite
46.8
Moat
-
|
1.28
-0.3
YoY
|
-
No YoY
|
|
|
NNVC
NanoViricides, Inc.
|
30.70M
|
Composite
53.4
Moat
-
|
2.21
-6.9
YoY
|
-
No YoY
|
|
30.40M
|
Composite
43.2
Moat
-
|
-
No YoY
|
-6.6%
-8.3
YoY
|
|
|
30.25M
|
Composite
39.5
Moat
-
|
13.99
+5.8
YoY
|
-33.8%
-14.9
YoY
|
|
|
30.13M
|
Composite
45.1
Moat
37.3
|
23.71
-25.7
YoY
|
-39.0%
-37.0
YoY
|
|
|
29.75M
|
Composite
27.6
Moat
-
|
12.56
+8.7
YoY
|
-
No YoY
|
|
|
29.70M
|
Composite
36.7
Moat
-
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
29.40M
|
Composite
45.8
Moat
-
|
19.37
-10.9
YoY
|
-22.4%
No YoY
|
|
|
29.00M
|
Composite
52.1
Moat
-
|
10.31
+0.4
YoY
|
-7.2%
+73.7
YoY
|
|
|
28.80M
|
Composite
29.8
Moat
-
|
-
No YoY
|
1.5%
-10.3
YoY
|
|
|
28.40M
|
Composite
40.4
Moat
-
|
32.53
+31.4
YoY
|
-
No YoY
|
|
|
28.26M
|
Composite
50.9
Moat
-
|
11.00
-6.2
YoY
|
-
No YoY
|
|
|
ABVC
ABVC Biopharma, Inc.
|
28.00M
|
Composite
51.0
Moat
-
|
2.08
+1.7
YoY
|
-9.2%
+35.2
YoY
|
|
FGEN
FibroGen, Inc
|
27.90M
|
Composite
52.0
Moat
-
|
4.39
-3.4
YoY
|
-4.4%
+2.2
YoY
|
|
27.70M
|
Composite
50.7
Moat
-
|
27.97
+15.0
YoY
|
-1.7%
+1.1
YoY
|
|
|
AYTU
Aytu BioPharma, Inc.
|
27.50M
|
Composite
34.1
Moat
-
|
191.8
+18.8
YoY
|
3.8%
+3.0
YoY
|
|
27.26M
|
Composite
42.5
Moat
27.2
|
2.57
-34.4
YoY
|
-304.4%
-205.2
YoY
|
|
|
FEMY
Femasys Inc.
|
27.12M
|
Composite
29.9
Moat
-
|
2.13
-21.0
YoY
|
-10.9%
+2.6
YoY
|
|
26.86M
|
Composite
47.0
Moat
-
|
45.89
+12.4
YoY
|
-3.5%
+96.9
YoY
|
|
|
26.51M
|
Composite
45.7
Moat
-
|
13.73
-6.3
YoY
|
-
No YoY
|
|
|
PLRZ
Polyrizon Ltd.
|
26.47M
|
Composite
57.8
Moat
-
|
26.72
+25.8
YoY
|
-
No YoY
|
|
CELU
Celularity Inc.
|
26.17M
|
Composite
39.1
Moat
-
|
1.38
+1.3
YoY
|
-71.1%
-67.7
YoY
|
|
NKGN
NKGen Biotech, Inc.
|
26.12M
|
Composite
41.0
Moat
-
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
25.80M
|
Composite
19.5
Moat
32.1
|
4.23
-1.5
YoY
|
-20.8%
-7.6
YoY
|
|
|
LGVN
Longeveron Inc.
|
24.94M
|
Composite
39.9
Moat
-
|
16.64
+13.3
YoY
|
-6.9%
+22.8
YoY
|
|
CRIS
Curis, Inc.
|
24.70M
|
Composite
45.9
Moat
-
|
6.07
-11.5
YoY
|
-4.1%
+0.7
YoY
|
|
24.30M
|
Composite
57.4
Moat
-
|
21.11
+10.1
YoY
|
-68.7%
-65.3
YoY
|
|
|
24.25M
|
Composite
51.3
Moat
-
|
1.87
-0.7
YoY
|
-47.4%
No YoY
|
|
|
24.20M
|
Composite
40.3
Moat
-
|
22.94
-32.5
YoY
|
-115.2%
-84.1
YoY
|
|
|
LTRN
Lantern Pharma Inc.
|
23.99M
|
Composite
49.9
Moat
-
|
16.18
-18.4
YoY
|
-
No YoY
|
|
TXMD
TherapeuticsMD, Inc.
|
23.30M
|
Composite
59.8
Moat
-
|
2.25
-3.2
YoY
|
-2.0%
+4.6
YoY
|
|
23.19M
|
Composite
50.0
Moat
-
|
13.51
+13.4
YoY
|
-
No YoY
|
|
|
AEON
AEON Biopharma, Inc.
|
22.91M
|
Composite
46.7
Moat
-
|
0.01
-1.3
YoY
|
-
No YoY
|
|
22.44M
|
Composite
42.9
Moat
-
|
21.73
-22.4
YoY
|
-46.9%
+40.2
YoY
|
|
|
21.60M
|
Composite
34.3
Moat
23.2
|
10.58
+8.1
YoY
|
-1.4%
+84.8
YoY
|
|
|
ICCM
IceCure Medical Ltd.
|
21.59M
|
Composite
35.0
Moat
-
|
7.22
-3.4
YoY
|
-4.8%
+0.1
YoY
|
|
21.56M
|
Composite
26.0
Moat
-
|
8.39
+7.7
YoY
|
-232.3%
-139.1
YoY
|
|
|
21.40M
|
Composite
33.7
Moat
-
|
16.13
-8.3
YoY
|
-1.0%
+38.5
YoY
|
|
|
21.37M
|
Composite
33.4
Moat
-
|
10.00
+2.1
YoY
|
-
No YoY
|
|
|
XCUR
Exicure, Inc.
|
21.35M
|
Composite
46.7
Moat
-
|
51.58
+50.6
YoY
|
-9.9%
-3.5
YoY
|
|
21.20M
|
Composite
46.7
Moat
36.2
|
5.97
-8.6
YoY
|
-299.3%
No YoY
|
|
|
20.70M
|
Composite
41.8
Moat
24.1
|
46.27
No YoY
|
-46.0%
-33.9
YoY
|
|
|
19.89M
|
Composite
40.1
Moat
-
|
15.34
-33.9
YoY
|
-
No YoY
|
|
|
VNRX
VolitionRX Limited
|
19.70M
|
Composite
34.5
Moat
-
|
1.51
-12.3
YoY
|
-21.8%
+24.3
YoY
|
|
19.61M
|
Composite
33.2
Moat
-
|
7.40
-1.7
YoY
|
-
No YoY
|
|
|
19.47M
|
Composite
48.2
Moat
-
|
1.36
+1.2
YoY
|
-132.2%
No YoY
|
|
|
19.40M
|
Composite
38.8
Moat
-
|
7.18
-14.4
YoY
|
-
No YoY
|
|
|
18.99M
|
Composite
38.7
Moat
-
|
16.34
-12.2
YoY
|
-
No YoY
|
|
|
18.86M
|
Composite
48.2
Moat
-
|
21.98
+17.4
YoY
|
-
No YoY
|
|
|
18.00M
|
Composite
51.3
Moat
-
|
266.0
No YoY
|
2.9%
-12.5
YoY
|
|
|
COSM
Cosmos Health Inc.
|
17.86M
|
Composite
29.5
Moat
-
|
0.52
-2.4
YoY
|
-28.0%
+12.9
YoY
|
|
IRIX
IRIDEX Corporation
|
17.80M
|
Composite
36.6
Moat
-
|
3.93
-8.6
YoY
|
-17.1%
+2.2
YoY
|
|
LPCN
Lipocine Inc.
|
17.70M
|
Composite
41.8
Moat
-
|
212.6
+190.3
YoY
|
-10.3%
-16.6
YoY
|
|
TRAW
Traws Pharma, Inc.
|
17.27M
|
Composite
45.8
Moat
-
|
8.59
-5.3
YoY
|
-110.2%
-20.4
YoY
|
|
AKAN
Akanda Corp.
|
16.57M
|
Composite
31.0
Moat
-
|
11.57
+10.9
YoY
|
-5.2%
+3.4
YoY
|
|
16.50M
|
Composite
44.4
Moat
-
|
8.23
-6.4
YoY
|
-
No YoY
|
|
|
15.90M
|
Composite
43.6
Moat
-
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
|
15.89M
|
Composite
32.2
Moat
-
|
0.26
+0.3
YoY
|
-107.6%
-104.4
YoY
|
|
|
INAB
IN8bio, Inc.
|
15.76M
|
Composite
55.4
Moat
-
|
5.53
-5.4
YoY
|
-
No YoY
|
|
15.27M
|
Composite
47.5
Moat
-
|
18.85
No YoY
|
1.0%
-9.0
YoY
|
|
|
BLRX
BioLineRx Ltd.
|
15.25M
|
Composite
63.2
Moat
-
|
5.35
-17.5
YoY
|
-66.2%
-57.2
YoY
|
|
15.10M
|
Composite
44.3
Moat
-
|
24.34
+4.2
YoY
|
-
No YoY
|
|
|
FLGC
Flora Growth Corp.
|
15.02M
|
Composite
40.0
Moat
-
|
14.35
+8.1
YoY
|
-21.8%
-7.9
YoY
|
|
14.90M
|
Composite
46.6
Moat
-
|
1.92
+0.5
YoY
|
-
No YoY
|
|
|
HOOK
HOOKIPA Pharma Inc.
|
14.18M
|
Composite
56.0
Moat
-
|
6.19
-18.2
YoY
|
-85.1%
-81.4
YoY
|
|
14.14M
|
Composite
38.8
Moat
-
|
12.10
-1.1
YoY
|
-
No YoY
|
|
|
14.09M
|
Composite
30.1
Moat
-
|
1.65
-4.8
YoY
|
-2.5%
+1.3
YoY
|
|
|
14.00M
|
Composite
39.9
Moat
-
|
5.87
+2.3
YoY
|
-
No YoY
|
|
|
13.69M
|
Composite
52.6
Moat
-
|
8.95
+4.7
YoY
|
-1.8%
+60.6
YoY
|
|
|
13.60M
|
Composite
38.8
Moat
59.0
|
19.72
+16.7
YoY
|
-
No YoY
|
|
|
13.30M
|
Composite
35.4
Moat
-
|
2.15
-9.8
YoY
|
-
No YoY
|
|
|
BFRI
Biofrontera Inc.
|
13.28M
|
Composite
26.9
Moat
-
|
6.91
+6.2
YoY
|
-46.1%
+20.1
YoY
|
|
13.24M
|
Composite
47.3
Moat
-
|
9.08
-0.4
YoY
|
-
No YoY
|
|
|
PASG
Passage Bio, Inc.
|
13.22M
|
Composite
50.1
Moat
-
|
19.21
+1.7
YoY
|
-
No YoY
|
|
13.17M
|
Composite
42.9
Moat
-
|
11.57
+10.9
YoY
|
-14.7%
-8.6
YoY
|
|
|
12.98M
|
Composite
50.2
Moat
-
|
2.04
-22.6
YoY
|
-
No YoY
|
|
|
AIMD
Ainos, Inc.
|
12.90M
|
Composite
33.8
Moat
-
|
8.04
+3.2
YoY
|
-667.7%
-559.6
YoY
|
|
12.89M
|
Composite
44.5
Moat
-
|
11.13
+1.1
YoY
|
-
No YoY
|
|
|
GTBP
GT Biopharma, Inc.
|
12.70M
|
Composite
42.5
Moat
-
|
3.67
-15.3
YoY
|
-
No YoY
|
|
BIVI
BioVie Inc.
|
12.50M
|
Composite
43.5
Moat
-
|
11.07
+0.8
YoY
|
-
No YoY
|
|
12.30M
|
Composite
42.5
Moat
-
|
7.68
+4.7
YoY
|
-
No YoY
|
|
|
BCDA
BioCardia, Inc.
|
11.93M
|
Composite
39.3
Moat
-
|
3.54
+2.2
YoY
|
-137.9%
-113.5
YoY
|
|
11.90M
|
Composite
37.6
Moat
53.2
|
-
No YoY
|
6.3%
-4.6
YoY
|
|
|
KAPA
Kairos Pharma, Ltd.
|
11.88M
|
Composite
58.7
Moat
-
|
3.86
-11.0
YoY
|
-
No YoY
|
|
RENB
Renovaro Inc.
|
11.60M
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
11.60M
|
Composite
41.0
Moat
-
|
21.47
+5.1
YoY
|
-
No YoY
|
|
|
11.28M
|
Composite
48.5
Moat
-
|
4.82
-5.1
YoY
|
-
No YoY
|
|
|
TRIB
Trinity Biotech plc
|
11.08M
|
Composite
34.6
Moat
-
|
14.79
+11.0
YoY
|
-25.2%
+2.9
YoY
|
|
10.89M
|
Composite
49.0
Moat
-
|
22.01
-8.6
YoY
|
-45.0%
No YoY
|
|
|
IMNN
Imunon, Inc.
|
10.60M
|
Composite
45.4
Moat
-
|
3.74
-6.2
YoY
|
-49.8%
-7.8
YoY
|
|
LFWD
Lifeward Ltd.
|
10.30M
|
Composite
38.9
Moat
-
|
3.73
-12.6
YoY
|
-76.2%
-74.5
YoY
|
|
NOTV
Inotiv, Inc.
|
10.30M
|
Composite
34.6
Moat
-
|
24.95
-12.8
YoY
|
-7.2%
+3.9
YoY
|
|
10.20M
|
Composite
29.1
Moat
-
|
2.88
-4.2
YoY
|
-1.6%
-0.1
YoY
|
|
|
10.11M
|
Composite
57.7
Moat
-
|
0.69
-5.9
YoY
|
11.6%
No YoY
|
|
|
XWEL
XWELL, Inc.
|
10.10M
|
Composite
35.9
Moat
-
|
12.86
-4.3
YoY
|
-35.7%
+28.4
YoY
|
|
9.99M
|
Composite
50.2
Moat
-
|
20.23
-1.1
YoY
|
-
No YoY
|
|
|
9.90M
|
Composite
55.1
Moat
-
|
3.08
-3.8
YoY
|
34.9%
No YoY
|
|
|
9.90M
|
Composite
31.9
Moat
-
|
5.00
+2.2
YoY
|
-7.3%
+3.6
YoY
|
|
|
CALC
CalciMedica, Inc.
|
9.80M
|
Composite
37.9
Moat
-
|
10.59
+5.4
YoY
|
-
No YoY
|
|
9.71M
|
Composite
36.9
Moat
-
|
5.92
+4.3
YoY
|
-74.3%
-73.1
YoY
|
|
|
YCBD
cbdMD, Inc.
|
9.58M
|
Composite
53.0
Moat
38.4
|
18.68
-64.7
YoY
|
-11.3%
+5.8
YoY
|
|
ELAB
PMGC Holdings Inc.
|
9.48M
|
Composite
46.5
Moat
-
|
8.71
-0.0
YoY
|
-2.3%
+947.0
YoY
|
|
NCNA
NuCana plc
|
9.20M
|
Composite
52.9
Moat
-
|
4.24
-3.6
YoY
|
-
No YoY
|
|
8.90M
|
Composite
24.3
Moat
-
|
1.83
-3.8
YoY
|
-95.6%
-92.5
YoY
|
|
|
8.82M
|
Composite
50.0
Moat
-
|
9.27
-8.4
YoY
|
-8.9%
+0.8
YoY
|
|
|
8.61M
|
Composite
43.4
Moat
-
|
0.25
-0.5
YoY
|
-
No YoY
|
|
|
8.60M
|
Composite
46.0
Moat
-
|
62.61
-217.3
YoY
|
-
No YoY
|
|
|
ZCMD
Zhongchao Inc.
|
8.56M
|
Composite
45.1
Moat
-
|
106.6
-111.7
YoY
|
-2.1%
+25.7
YoY
|
|
TNON
Tenon Medical, Inc.
|
8.43M
|
Composite
34.8
Moat
-
|
7.94
+5.5
YoY
|
-4.2%
+1.2
YoY
|
|
EVGN
Evogene Ltd.
|
8.36M
|
Composite
58.6
Moat
-
|
9.33
-7.9
YoY
|
-2.6%
+2.1
YoY
|
|
VSEE
VSee Health, Inc.
|
8.30M
|
Composite
26.7
Moat
-
|
0.68
-1.6
YoY
|
-6.0%
+39.0
YoY
|
|
8.23M
|
Composite
30.5
Moat
-
|
11.63
+6.4
YoY
|
-82.6%
+163.0
YoY
|
|
|
8.20M
|
Composite
45.9
Moat
-
|
13.45
-1.5
YoY
|
-522.2%
+102.3
YoY
|
|
|
ACON
Aclarion, Inc.
|
8.08M
|
Composite
37.5
Moat
-
|
1.03
-2.3
YoY
|
-120.6%
-55.9
YoY
|
|
GNPX
Genprex, Inc.
|
8.00M
|
Composite
37.3
Moat
-
|
1.12
-2.1
YoY
|
-
No YoY
|
|
7.67M
|
Composite
47.3
Moat
-
|
4.28
-4.9
YoY
|
-
No YoY
|
|
|
7.50M
|
Composite
34.5
Moat
35.1
|
732.8
+717.2
YoY
|
-26.0%
+10.9
YoY
|
|
|
7.48M
|
Composite
54.7
Moat
-
|
8.48
-25.6
YoY
|
-4.8%
No YoY
|
|
|
7.30M
|
Composite
42.4
Moat
-
|
1.27
-5.7
YoY
|
-
No YoY
|
|
|
MTVA
MetaVia Inc.
|
7.23M
|
Composite
49.7
Moat
-
|
7.78
-17.2
YoY
|
-
No YoY
|
|
BCAB
BioAtla, Inc.
|
7.21M
|
Composite
45.5
Moat
-
|
8.18
-4.7
YoY
|
-6.7%
+379.0
YoY
|
|
7.18M
|
Composite
37.7
Moat
-
|
7.48
+1.7
YoY
|
-6.8%
-5.4
YoY
|
|
|
7.15M
|
Composite
47.8
Moat
-
|
0.46
-4.6
YoY
|
-
No YoY
|
|
|
7.10M
|
Composite
57.9
Moat
-
|
26.26
+0.1
YoY
|
-1.7%
+0.1
YoY
|
|
|
7.08M
|
Composite
36.4
Moat
-
|
10.59
+1.4
YoY
|
-46.0%
+5.5
YoY
|
|
|
7.04M
|
Composite
41.6
Moat
-
|
1.31
-3.1
YoY
|
-29.6%
+274.4
YoY
|
|
|
7.04M
|
Composite
40.5
Moat
-
|
12.39
-0.3
YoY
|
-12.1%
-1.0
YoY
|
|
|
SYBX
Synlogic, Inc.
|
6.96M
|
Composite
41.6
Moat
-
|
7.15
-4.0
YoY
|
-1972.1%
-1955.8
YoY
|
|
6.93M
|
Composite
45.7
Moat
-
|
8.82
+5.7
YoY
|
-24.6%
-11.3
YoY
|
|
|
6.90M
|
Composite
40.5
Moat
-
|
5.23
+3.4
YoY
|
-
No YoY
|
|
|
BMRA
Biomerica, Inc.
|
6.80M
|
Composite
36.7
Moat
-
|
7.49
-1.8
YoY
|
-96.7%
-95.5
YoY
|
|
FBLG
FibroBiologics, Inc.
|
6.72M
|
Composite
44.7
Moat
-
|
14.10
-3.1
YoY
|
-
No YoY
|
|
IMRN
Immuron Limited
|
6.70M
|
Composite
41.8
Moat
-
|
5.53
-86.1
YoY
|
-73.5%
-72.4
YoY
|
|
6.60M
|
Composite
35.6
Moat
-
|
30.75
+1.2
YoY
|
-
No YoY
|
|
|
6.59M
|
Composite
42.9
Moat
-
|
2.48
-0.3
YoY
|
-
No YoY
|
|
|
MLEC
Moolec Science SA
|
6.48M
|
Composite
38.8
Moat
-
|
0.83
-6.1
YoY
|
-1.1%
-10.0
YoY
|
|
6.41M
|
Composite
26.3
Moat
-
|
11.79
-7.1
YoY
|
-
No YoY
|
|
|
PPBT
Purple Biotech Ltd.
|
6.39M
|
Composite
55.9
Moat
54.7
|
7.12
-2.2
YoY
|
-
No YoY
|
|
6.31M
|
Composite
38.8
Moat
-
|
3.48
+1.5
YoY
|
-
No YoY
|
|
|
6.30M
|
Composite
44.8
Moat
-
|
2.63
+0.2
YoY
|
-481.2%
+5217.4
YoY
|
|
|
6.20M
|
Composite
41.5
Moat
-
|
15.65
-5.0
YoY
|
-28.8%
+75.0
YoY
|
|
|
6.03M
|
Composite
25.1
Moat
-
|
5.24
+1.7
YoY
|
-
No YoY
|
|
|
PTHL
Pheton Holdings Ltd
|
6.01M
|
Composite
37.8
Moat
-
|
95.38
+54.3
YoY
|
-1.5%
+39.7
YoY
|
|
MGRX
Mangoceuticals, Inc.
|
5.96M
|
Composite
28.7
Moat
-
|
0.14
-1.1
YoY
|
-14.1%
-1.5
YoY
|
|
XAIR
Beyond Air, Inc.
|
5.90M
|
Composite
32.9
Moat
-
|
2.17
-5.2
YoY
|
-12.0%
+42.3
YoY
|
|
5.80M
|
Composite
42.6
Moat
-
|
4.40
-12.9
YoY
|
-9.2%
-7.5
YoY
|
|
|
HSCS
HeartSciences Inc.
|
5.77M
|
Composite
32.2
Moat
11.3
|
1.78
-9.7
YoY
|
-1920.1%
-1581.1
YoY
|
|
CODX
Co-Diagnostics, Inc.
|
5.70M
|
Composite
34.4
Moat
-
|
12.24
-19.6
YoY
|
-10.2%
-4.0
YoY
|
|
5.70M
|
Composite
36.8
Moat
-
|
10.10
-2.1
YoY
|
-
No YoY
|
|
|
5.60M
|
Composite
42.5
Moat
-
|
4.53
+4.1
YoY
|
-
No YoY
|
|
|
MBIO
Mustang Bio, Inc.
|
5.50M
|
Composite
57.5
Moat
-
|
7.19
+5.7
YoY
|
-
No YoY
|
|
5.39M
|
Composite
45.1
Moat
-
|
18.81
+16.1
YoY
|
-239.8%
+184.6
YoY
|
|
|
5.30M
|
Composite
40.2
Moat
-
|
10.14
-105.7
YoY
|
-33.5%
+35.1
YoY
|
|
|
5.30M
|
Composite
41.7
Moat
-
|
9.28
-13.0
YoY
|
-16.7%
+3.2
YoY
|
|
|
5.25M
|
Composite
31.9
Moat
-
|
1.26
-6.6
YoY
|
-3.4%
-0.1
YoY
|
|
|
5.21M
|
Composite
32.4
Moat
-
|
92.60
+17.5
YoY
|
-1.5%
-0.2
YoY
|
|
|
5.13M
|
Composite
28.0
Moat
-
|
12.57
+0.7
YoY
|
-46.4%
-45.2
YoY
|
|
|
5.11M
|
Composite
45.0
Moat
-
|
3.40
-10.5
YoY
|
-
No YoY
|
|
|
5.10M
|
Composite
32.7
Moat
-
|
5.91
+4.0
YoY
|
-1.5%
+3.3
YoY
|
|
|
NXGL
NexGel, Inc
|
5.09M
|
Composite
34.0
Moat
-
|
5.61
-4.4
YoY
|
-40.9%
+44.1
YoY
|
|
PHGE
BiomX Inc.
|
5.03M
|
Composite
37.4
Moat
-
|
5.47
-2.9
YoY
|
-
No YoY
|
|
GOVX
GeoVax Labs, Inc.
|
4.77M
|
Composite
38.7
Moat
-
|
2.68
-0.4
YoY
|
-6.4%
+165.7
YoY
|
|
GELS
Gelteq Limited
|
4.77M
|
Composite
30.8
Moat
-
|
0.75
+0.5
YoY
|
-29.9%
+12.4
YoY
|
|
MYNZ
Mainz Biomed N.V.
|
4.75M
|
Composite
26.4
Moat
-
|
4.38
+0.5
YoY
|
-20.6%
+9.2
YoY
|
|
PULM
Pulmatrix, Inc.
|
4.75M
|
Composite
53.6
Moat
-
|
10.66
-3.7
YoY
|
-91.5%
-89.5
YoY
|
|
4.60M
|
Composite
43.1
Moat
-
|
5.63
-6.3
YoY
|
-
No YoY
|
|
|
4.56M
|
Composite
30.9
Moat
-
|
0.22
-6.7
YoY
|
-39.2%
-21.1
YoY
|
|
|
4.40M
|
Composite
47.8
Moat
-
|
5.50
-5.3
YoY
|
-21.7%
-14.0
YoY
|
|
|
4.38M
|
Composite
46.7
Moat
-
|
3.53
-2.1
YoY
|
-16.0%
+4.3
YoY
|
|
|
4.36M
|
Composite
33.3
Moat
-
|
13.28
-2.3
YoY
|
-
No YoY
|
|
|
4.36M
|
Composite
29.5
Moat
-
|
3.14
-8.6
YoY
|
-
No YoY
|
|
|
4.35M
|
Composite
42.7
Moat
-
|
6.61
-11.9
YoY
|
-1.4%
+73.2
YoY
|
|
|
ISPC
iSpecimen Inc.
|
4.32M
|
Composite
27.1
Moat
-
|
2.73
-7.6
YoY
|
-1.4%
-0.2
YoY
|
|
ALZN
Alzamend Neuro, Inc.
|
4.19M
|
Composite
52.3
Moat
-
|
7.21
+6.7
YoY
|
-
No YoY
|
|
4.10M
|
Composite
59.1
Moat
-
|
31.29
+6.6
YoY
|
-
No YoY
|
|
|
SNYR
Synergy CHC Corp.
|
4.10M
|
Composite
43.8
Moat
-
|
1.72
No YoY
|
16.7%
-8.6
YoY
|
|
AZTR
Azitra Inc
|
3.97M
|
Composite
31.0
Moat
-
|
5.37
+2.4
YoY
|
-1464.7%
-1453.8
YoY
|
|
3.90M
|
Composite
44.8
Moat
25.1
|
3.21
-4.2
YoY
|
-116.3%
+41.7
YoY
|
|
|
3.79M
|
Composite
40.7
Moat
-
|
4.26
-15.5
YoY
|
-
No YoY
|
|
|
3.72M
|
Composite
52.2
Moat
-
|
6.46
+0.9
YoY
|
-
No YoY
|
|
|
SPRC
SciSparc Ltd.
|
3.61M
|
Composite
33.3
Moat
-
|
4.84
-5.5
YoY
|
-5.5%
-3.5
YoY
|
|
3.60M
|
Composite
36.7
Moat
-
|
5.60
+4.4
YoY
|
-
No YoY
|
|
|
GRI
GRI Bio, Inc.
|
3.41M
|
Composite
41.4
Moat
-
|
9.69
+2.7
YoY
|
-
No YoY
|
|
3.24M
|
Composite
44.9
Moat
-
|
17.11
+5.8
YoY
|
-1.6%
+0.2
YoY
|
|
|
SNGX
Soligenix, Inc.
|
3.20M
|
Composite
41.9
Moat
-
|
11.17
-0.6
YoY
|
-56.4%
+331.1
YoY
|
|
3.10M
|
Composite
32.2
Moat
-
|
8.63
+2.2
YoY
|
-20.7%
+14.7
YoY
|
|
|
2.96M
|
Composite
32.4
Moat
-
|
4.20
-0.6
YoY
|
-7.3%
-0.2
YoY
|
|
|
2.91M
|
Composite
41.2
Moat
-
|
10.81
+3.5
YoY
|
-
No YoY
|
|
|
NUWE
Nuwellis, Inc.
|
2.87M
|
Composite
50.0
Moat
-
|
6.37
+3.8
YoY
|
-1.3%
+0.7
YoY
|
|
2.87M
|
Composite
37.0
Moat
-
|
1.63
-8.9
YoY
|
-21.0%
-8.3
YoY
|
|
|
VCNX
Vaccinex, Inc.
|
2.81M
|
Composite
33.0
Moat
-
|
0.82
-0.0
YoY
|
-31.2%
+9.0
YoY
|
|
OGEN
Oragenics Inc.
|
2.70M
|
Composite
53.7
Moat
-
|
1.21
-4.5
YoY
|
-
No YoY
|
|
2.51M
|
Composite
36.5
Moat
-
|
3.36
-11.9
YoY
|
-
No YoY
|
|
|
2.51M
|
Composite
38.8
Moat
-
|
11.12
+4.2
YoY
|
-973.4%
-931.9
YoY
|
|
|
2.49M
|
Composite
34.3
Moat
-
|
3.72
+1.6
YoY
|
-26.8%
+12.1
YoY
|
|
|
2.43M
|
Composite
40.9
Moat
-
|
5.84
+5.0
YoY
|
-514.0%
-490.6
YoY
|
|
|
HCWB
HCW Biologics Inc.
|
2.36M
|
Composite
37.2
Moat
-
|
3.94
+2.0
YoY
|
-11.3%
-2.2
YoY
|
|
BBLG
Bone Biologics Corp
|
2.32M
|
Composite
53.4
Moat
-
|
9.67
+5.9
YoY
|
-
No YoY
|
|
SYRA
Syra Health Corp.
|
2.27M
|
Composite
30.1
Moat
-
|
9.80
-4.5
YoY
|
-47.2%
+5.2
YoY
|
|
2.26M
|
Composite
39.6
Moat
-
|
6.50
+1.5
YoY
|
-
No YoY
|
|
|
2.15M
|
Composite
43.6
Moat
-
|
9.73
-9.4
YoY
|
-17.4%
-14.3
YoY
|
|
|
1.91M
|
Composite
39.9
Moat
-
|
1.70
-10.5
YoY
|
-
No YoY
|
|
|
1.88M
|
Composite
48.3
Moat
-
|
3.72
-2.5
YoY
|
-13.1%
No YoY
|
|
|
1.88M
|
Composite
27.9
Moat
-
|
6.60
+3.4
YoY
|
-37.4%
No YoY
|
|
|
1.81M
|
Composite
52.8
Moat
-
|
3.45
+1.2
YoY
|
-
No YoY
|
|
|
1.69M
|
Composite
41.1
Moat
-
|
79.79
+42.6
YoY
|
-16.3%
+18.5
YoY
|
|
|
GCTK
GlucoTrack, Inc.
|
1.67M
|
Composite
28.2
Moat
-
|
5.40
-2.8
YoY
|
-
No YoY
|
|
IMCC
IM Cannabis Corp.
|
1.63M
|
Composite
37.1
Moat
-
|
9.62
+6.9
YoY
|
-18.9%
+6.0
YoY
|
|
1.62M
|
Composite
39.6
Moat
-
|
2.43
-1.9
YoY
|
-
No YoY
|
|
|
PRFX
PainReform Ltd.
|
1.61M
|
Composite
33.5
Moat
-
|
4.05
-10.4
YoY
|
-
No YoY
|
|
1.60M
|
Composite
47.7
Moat
-
|
35.32
+31.4
YoY
|
-9.1%
+23.1
YoY
|
|
|
1.42M
|
Composite
44.2
Moat
37.7
|
156.9
+86.3
YoY
|
-16.1%
+2.9
YoY
|
|
|
1.30M
|
Composite
44.5
Moat
36.4
|
6.96
-12.5
YoY
|
-39.6%
+2.5
YoY
|
|
|
1.29M
|
Composite
43.5
Moat
-
|
3.32
-3.7
YoY
|
-
No YoY
|
|
|
1.28M
|
Composite
41.1
Moat
-
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
JAGX
Jaguar Health, Inc.
|
1.20M
|
Composite
44.4
Moat
-
|
3.27
+0.9
YoY
|
-2.6%
+0.8
YoY
|
|
790,273
|
Composite
45.5
Moat
-
|
0.66
+0.3
YoY
|
-21.4%
-22.2
YoY
|
|
|
VERO
Venus Concept Inc.
|
563,314
|
Composite
26.0
Moat
-
|
4.63
-0.4
YoY
|
-41.9%
-4.9
YoY
|
|
WORX
SCWorx Corp.
|
523,181
|
Composite
31.0
Moat
-
|
1.18
-0.2
YoY
|
-42.1%
-4.0
YoY
|
|
516,620
|
Composite
42.3
Moat
-
|
1.33
+0.2
YoY
|
-
No YoY
|
|
|
497,436
|
Composite
50.0
Moat
-
|
8.07
+1.8
YoY
|
-
No YoY
|
|
|
441,572
|
Composite
42.3
Moat
-
|
0.27
-4.1
YoY
|
-
No YoY
|
|
|
MSPR
MSP Recovery, Inc.
|
413,957
|
Composite
24.4
Moat
-
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
LGMK
LogicMark, Inc.
|
373,752
|
Composite
42.9
Moat
-
|
10.74
-7.1
YoY
|
-77.5%
-1.8
YoY
|
|
373,266
|
Composite
44.2
Moat
-
|
0.29
+0.2
YoY
|
-1.5%
+138.2
YoY
|
|
|
337,087
|
Composite
41.1
Moat
-
|
1.39
-2.5
YoY
|
-
No YoY
|
|
|
PRPH
ProPhase Labs, Inc.
|
331,590
|
Composite
25.2
Moat
-
|
0.46
-4.3
YoY
|
-5.7%
+55.0
YoY
|
|
ONCO
Onconetix, Inc.
|
311,817
|
Composite
37.3
Moat
-
|
0.74
-3.3
YoY
|
-4.1%
+301.2
YoY
|
|
IOBT
IO Biotech, Inc.
|
309,380
|
Composite
46.4
Moat
-
|
8.75
-15.2
YoY
|
-
No YoY
|
|
211,861
|
Composite
32.1
Moat
-
|
17.10
-3.9
YoY
|
-2.0%
-0.2
YoY
|
|
|
191,166
|
Composite
29.7
Moat
-
|
0.05
-2.1
YoY
|
-
No YoY
|
|
|
BACK
IMAC Holdings, Inc.
|
162,753
|
Composite
22.1
Moat
-
|
1.91
+1.0
YoY
|
-78.0%
-8.9
YoY
|
|
161,729
|
Composite
39.6
Moat
-
|
6.64
-5.9
YoY
|
-9.5%
+1.1
YoY
|
|
|
ADTX
Aditxt, Inc.
|
122,103
|
Composite
35.4
Moat
-
|
0.60
+0.5
YoY
|
-208.0%
-167.6
YoY
|
|
92,946
|
Composite
38.0
Moat
-
|
0.00
-0.0
YoY
|
-
No YoY
|
|
|
VINC
Vincerx Pharma, Inc.
|
65,428
|
Composite
40.9
Moat
-
|
2.29
-1.5
YoY
|
-
No YoY
|
|
DHAI
DIH Holding US, Inc.
|
62,779
|
Composite
45.1
Moat
-
|
0.21
-1.9
YoY
|
-7.7%
-3.7
YoY
|
|
16,738
|
Composite
52.9
Moat
-
|
3.59
-7.9
YoY
|
-3.2%
+2.8
YoY
|
|
|
12,074
|
Composite
45.7
Moat
-
|
15.26
-4.5
YoY
|
-12.7%
-4.2
YoY
|
|
|
TTOO
T2 Biosystems, Inc.
|
5,609
|
Composite
23.6
Moat
-
|
3.91
+1.5
YoY
|
-6.6%
-4.1
YoY
|
|
ICCT
iCoreConnect Inc.
|
2,438
|
Composite
26.7
Moat
-
|
0.75
-0.9
YoY
|
-1.4%
-0.2
YoY
|
|
941
|
Composite
36.1
Moat
-
|
7.46
-4.7
YoY
|
-
No YoY
|
|
|
621
|
Composite
36.0
Moat
-
|
1.09
-10.0
YoY
|
-
No YoY
|
|
|
OTRK
Ontrak, Inc.
|
7
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
53.1
Moat
-
|
3.10
-1.9
YoY
|
16.2%
+26.0
YoY
|
|
|
ABPWW
Abpro Holdings, Inc.
|
-
|
Composite
42.8
Moat
-
|
3.79
+2.6
YoY
|
-54.2%
+42.1
YoY
|
|
ACCD
Accolade, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
51.7
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
ACONW
Aclarion, Inc.
|
-
|
Composite
38.1
Moat
-
|
1.03
-2.3
YoY
|
-120.6%
-55.9
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
48.1
Moat
-
|
-
No YoY
|
-139.2%
-103.3
YoY
|
|
|
AFMD
Affimed N.V.
|
-
|
Composite
34.4
Moat
-
|
-
No YoY
|
-12.9%
-10.8
YoY
|
|
-
|
Composite
34.4
Moat
-
|
8.04
+3.2
YoY
|
-667.7%
-559.6
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
ALLK
Allakos Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
ALVOW
Alvotech Warrant
|
-
|
Composite
55.7
Moat
-
|
2.61
+2.2
YoY
|
14.2%
+18.1
YoY
|
|
ALVR
AlloVir, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
AMED
Amedisys Inc
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
39.6
Moat
-
|
176.3
+134.0
YoY
|
-0.9%
+0.5
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
43.5
Moat
-
|
11.30
+0.4
YoY
|
-229.2%
-222.8
YoY
|
|
|
-
|
Composite
39.8
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
ATNFW
180 Life Sciences Corp.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
46.5
Moat
-
|
48.49
+5.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
59.5
Moat
-
|
18.87
+9.1
YoY
|
-25.1%
-20.1
YoY
|
|
|
AVGR
Avinger, Inc.
|
-
|
Composite
25.7
Moat
-
|
-
No YoY
|
-2.2%
-0.2
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
26.1
Moat
-
|
-
No YoY
|
-3.0%
+1.5
YoY
|
|
|
-
|
Composite
51.3
Moat
-
|
9.67
+5.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
42.0
Moat
-
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
58.4
Moat
-
|
5.65
-12.1
YoY
|
41.3%
+1.1
YoY
|
|
|
-
|
Composite
26.4
Moat
-
|
6.91
+6.2
YoY
|
-46.1%
+20.1
YoY
|
|
|
BGNE
BeiGene, Ltd.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
28.9
Moat
-
|
1.83
-3.8
YoY
|
-95.6%
-92.5
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
BLUE
bluebird bio, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
62.3
Moat
-
|
35.15
No YoY
|
1.8%
+0.2
YoY
|
|
|
CANB
CAN B CORP.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
64.9
Moat
-
|
-
No YoY
|
8.8%
+12.2
YoY
|
|
|
-
|
Composite
55.3
Moat
-
|
-
No YoY
|
8.2%
+48.5
YoY
|
|
|
-
|
Composite
44.2
Moat
-
|
18.81
+16.1
YoY
|
-239.8%
+184.6
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
39.4
Moat
43.2
|
0.69
-5.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
40.6
Moat
-
|
12.90
-6.2
YoY
|
-138.1%
-137.0
YoY
|
|
|
CELUW
Celularity Inc.
|
-
|
Composite
41.0
Moat
-
|
1.38
+1.3
YoY
|
-71.1%
-67.7
YoY
|
|
-
|
Composite
39.6
Moat
-
|
3.32
-3.7
YoY
|
-
No YoY
|
|
|
CHEK
Check-Cap Ltd.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
CINGW
Cingulate Inc. Warrants
|
-
|
Composite
46.1
Moat
-
|
7.94
+7.9
YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
CMRX
Chimerix, Inc.
|
-
|
Composite
45.1
Moat
-
|
-
No YoY
|
-455.5%
-168.3
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
CUTR
Cutera, Inc.
|
-
|
Composite
29.4
Moat
-
|
-
No YoY
|
-73.6%
-58.4
YoY
|
|
CVAC
CureVac N.V.
|
-
|
Composite
69.2
Moat
-
|
18.15
-2.8
YoY
|
33.2%
+38.3
YoY
|
|
CYBN
Cybin Inc.
|
-
|
Composite
47.0
Moat
-
|
15.99
-20.4
YoY
|
-
No YoY
|
|
-
|
Composite
51.4
Moat
-
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
41.5
Moat
-
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
CYTHW
Cyclo Therapeutics, Inc.
|
-
|
Composite
34.9
Moat
-
|
-
No YoY
|
-18.6%
0.0
YoY
|
|
-
|
Composite
41.0
Moat
-
|
-
No YoY
|
-4.0%
-3.6
YoY
|
|
|
-
|
Composite
37.6
Moat
-
|
3.40
-10.5
YoY
|
-
No YoY
|
|
|
DRRX
DURECT Corporation
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
45.1
Moat
-
|
36.15
-18.5
YoY
|
-
No YoY
|
|
|
-
|
Composite
63.0
Moat
-
|
-
No YoY
|
-1.5%
+9.6
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
40.4
Moat
-
|
23.43
-35.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
EPIX
ESSA Pharma Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
31.8
Moat
-
|
3.11
-19.2
YoY
|
-
No YoY
|
|
|
ETNB
89bio, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
28.4
Moat
-
|
1.40
+0.6
YoY
|
-64.3%
-63.2
YoY
|
|
|
EVOK
Evoke Pharma, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
EYEN
Eyenovia, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
FNA
Paragon 28, Inc.
|
-
|
Composite
45.4
Moat
-
|
-
No YoY
|
-15.9%
+1.3
YoY
|
|
GBIO
Generation Bio Co.
|
-
|
Composite
50.6
Moat
-
|
25.10
-35.0
YoY
|
-4.0%
+19.5
YoY
|
|
-
|
Composite
19.1
Moat
-
|
-
No YoY
|
-85.3%
-84.3
YoY
|
|
|
GLYC
GlycoMimetics, Inc.
|
-
|
Composite
43.5
Moat
-
|
-
No YoY
|
-3927.5%
-3294.9
YoY
|
|
GNFT
GENFIT S.A.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
GOVXW
GeoVax Labs, Inc.
|
-
|
Composite
39.6
Moat
-
|
2.68
-0.4
YoY
|
-6.4%
+165.7
YoY
|
|
HLVX
HilleVax, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
31.1
Moat
-
|
1.78
-9.7
YoY
|
-1920.1%
-1581.1
YoY
|
|
|
HUMAW
Humacyte, Inc.
|
-
|
Composite
46.4
Moat
-
|
5.50
-7.7
YoY
|
-
No YoY
|
|
ICAD
icad inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
30.3
Moat
-
|
7.40
-1.7
YoY
|
-
No YoY
|
|
|
IKNA
Ikena Oncology, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
IMAB
I-MAB
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
IMTXW
Immatics N.V.
|
-
|
Composite
49.6
Moat
-
|
45.90
+25.4
YoY
|
-24.8%
-22.9
YoY
|
|
INZY
Inozyme Pharma, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
45.3
Moat
-
|
13.73
-6.3
YoY
|
-
No YoY
|
|
|
KDLY
Kindly MD, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
KDLYW
Kindly MD, Inc. Warrants
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
45.5
Moat
-
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
KRON
Kronos Bio, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
42.3
Moat
-
|
5.97
-8.6
YoY
|
-299.3%
No YoY
|
|
|
LEXXW
Lexaria Bioscience Corp.
|
-
|
Composite
43.7
Moat
-
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
-
|
Composite
42.0
Moat
-
|
2.07
-12.9
YoY
|
-7.6%
+1.9
YoY
|
|
|
-
|
Composite
31.8
Moat
-
|
3.94
-7.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
62.4
Moat
-
|
-
No YoY
|
-14.0%
+63.7
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
37.5
Moat
23.8
|
-
No YoY
|
-1.5%
-0.4
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
41.2
Moat
-
|
-
No YoY
|
14.8%
-0.3
YoY
|
|
|
-
|
Composite
39.3
Moat
-
|
0.83
-6.1
YoY
|
-1.1%
-10.0
YoY
|
|
|
MODV
ModivCare Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
54.0
Moat
-
|
19.62
+4.8
YoY
|
-1.8%
+2.8
YoY
|
|
|
MRUS
Merus N.V.
|
-
|
Composite
45.5
Moat
-
|
34.68
+4.8
YoY
|
-7.5%
-4.0
YoY
|
|
MSPRW
MSP Recovery, Inc.
|
-
|
Composite
24.8
Moat
-
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
MSPRZ
MSP Recovery, Inc.
|
-
|
Composite
24.8
Moat
-
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
MTSR
Metsera, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
MURA
Mural Oncology plc
|
-
|
Composite
51.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
50.5
Moat
-
|
63.13
+34.2
YoY
|
-10.0%
-6.2
YoY
|
|
|
NAOV
NanoVibronix, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
NARI
Inari Medical, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
NEUE
NeueHealth, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
49.1
Moat
-
|
0.66
+0.3
YoY
|
-21.4%
-22.2
YoY
|
|
|
-
|
Composite
42.0
Moat
-
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
NLSPW
NLS Pharmaceutics Ltd.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
31.2
Moat
-
|
4.00
+0.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
38.8
Moat
-
|
1.63
-0.9
YoY
|
-
No YoY
|
|
|
NTRBW
Nutriband Inc. Warrant
|
-
|
Composite
35.5
Moat
-
|
11.18
+9.5
YoY
|
-3.1%
-0.8
YoY
|
|
NURO
NeuroMetrix, Inc.
|
-
|
Composite
34.6
Moat
-
|
-
No YoY
|
-2.9%
-1.7
YoY
|
|
NVRO
Nevro Corp.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
NXGLW
NexGel, Inc Warrant
|
-
|
Composite
35.9
Moat
-
|
5.61
-4.4
YoY
|
-40.9%
+44.1
YoY
|
|
NXLIW
Nexalin Technology, Inc.
|
-
|
Composite
35.6
Moat
-
|
10.59
+1.4
YoY
|
-46.0%
+5.5
YoY
|
|
OABIW
OmniAb, Inc.
|
-
|
Composite
53.6
Moat
-
|
17.98
-277.3
YoY
|
-2.8%
-0.8
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
29.8
Moat
46.7
|
-
No YoY
|
2.8%
-0.2
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
40.1
Moat
-
|
-
No YoY
|
-53.1%
-23.0
YoY
|
|
|
ONMDW
OneMedNet Corporation
|
-
|
Composite
27.6
Moat
-
|
5.19
+5.1
YoY
|
-14.9%
-8.2
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
OPT
Opthea Limited
|
-
|
Composite
29.7
Moat
20.5
|
-
No YoY
|
-1538.9%
-152.4
YoY
|
|
OPTN
OptiNose, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
OTRKP
Ontrak, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
PAVMZ
PAVmed Inc. - Series Z
|
-
|
Composite
31.0
Moat
-
|
0.42
-4.1
YoY
|
-14.8%
+13.2
YoY
|
|
-
|
Composite
41.4
Moat
-
|
19.72
+16.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
PIIIW
P3 Health Partners Inc.
|
-
|
Composite
20.3
Moat
32.1
|
4.23
-1.5
YoY
|
-20.8%
-7.6
YoY
|
|
PINC
Premier, Inc.
|
-
|
Composite
50.6
Moat
-
|
-
No YoY
|
0.1%
-11.0
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
PRENW
Prenetics Global Limited
|
-
|
Composite
35.3
Moat
-
|
26.11
-37.3
YoY
|
-40.5%
-38.8
YoY
|
|
PROC
Procaps Group, S.A.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
PRTG
Portage Biotech Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
42.9
Moat
-
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
QSIAW
Quantum-Si incorporated
|
-
|
Composite
40.2
Moat
-
|
28.65
-4.2
YoY
|
-35.5%
+67.2
YoY
|
|
-
|
Composite
45.4
Moat
-
|
4.26
-15.5
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
69.6
Moat
58.3
|
23.98
+2.9
YoY
|
-1.7%
+0.5
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
40.8
Moat
-
|
49.28
-14.1
YoY
|
-42.1%
-34.8
YoY
|
|
|
-
|
Composite
49.6
Moat
-
|
-
No YoY
|
-1.4%
+0.7
YoY
|
|
|
-
|
Composite
39.9
Moat
-
|
4.82
-5.1
YoY
|
-
No YoY
|
|
|
-
|
Composite
56.5
Moat
-
|
7.26
-19.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
47.5
Moat
-
|
9.28
-13.0
YoY
|
-16.7%
+3.2
YoY
|
|
|
SCLXW
Scilex Holding Company
|
-
|
Composite
27.5
Moat
-
|
2.27
+1.0
YoY
|
-1.6%
+0.6
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SHLT
SHL Telemedicine Ltd
|
-
|
Composite
29.8
Moat
-
|
-
No YoY
|
-47.2%
-31.4
YoY
|
|
SLRN
ACELYRIN, INC.
|
-
|
Composite
34.1
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
39.8
Moat
-
|
1.70
-10.5
YoY
|
-
No YoY
|
|
|
-
|
Composite
49.5
Moat
-
|
-
No YoY
|
37.2%
+3.5
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
SRDX
Surmodics, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
SRZNW
Surrozen, Inc. Warrant
|
-
|
Composite
34.4
Moat
-
|
23.53
+12.8
YoY
|
-2.4%
+1.2
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
36.1
Moat
-
|
-
No YoY
|
-44.9%
+42.1
YoY
|
|
|
-
|
Composite
44.4
Moat
-
|
73.24
No YoY
|
-2.7%
-3.6
YoY
|
|
|
-
|
Composite
29.8
Moat
-
|
1.50
-2.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
53.1
Moat
-
|
-
No YoY
|
-3.1%
+0.5
YoY
|
|
|
-
|
Composite
43.8
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
37.0
Moat
-
|
2.50
-0.3
YoY
|
-1.2%
+1.7
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
25.0
Moat
-
|
22.46
-4.9
YoY
|
-15.3%
+3.3
YoY
|
|
|
TRML
Tourmaline Bio, Inc.
|
-
|
Composite
41.8
Moat
-
|
-
No YoY
|
-
No YoY
|
|
TRVN
Trevena, Inc.
|
-
|
Composite
34.4
Moat
-
|
11.98
+3.0
YoY
|
-11.3%
-146.2
YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
TSVT
2seventy bio, Inc.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
40.8
Moat
-
|
1.28
-0.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
37.1
Moat
-
|
16.15
-14.7
YoY
|
-
No YoY
|
|
|
VRNA
Verona Pharma plc
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
WGSWW
GeneDx Holdings Corp.
|
-
|
Composite
55.6
Moat
-
|
59.45
+50.8
YoY
|
-7.6%
+76.4
YoY
|
|
-
|
Composite
64.3
Moat
-
|
91.81
-9.6
YoY
|
-88.8%
-84.2
YoY
|
|
|
-
|
Composite
64.5
Moat
-
|
91.81
-9.6
YoY
|
-88.8%
-84.2
YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
|
ZIMV
ZimVie Inc.
|
-
|
Composite
48.5
Moat
-
|
-
No YoY
|
-4.6%
+2.2
YoY
|
|
ZOM
Zomedica Corp.
|
-
|
Composite
0.0
Moat
-
|
-
No YoY
|
-
No YoY
|
|
ZYXI
Zynex, Inc.
|
-
|
Composite
19.0
Moat
-
|
-
No YoY
|
3.1%
-2.7
YoY
|
Sector benchmarks show the distribution of key financial metrics across companies in Healthcare. Use them to contextualise individual company figures against the sector norm. The outer chart band shows the broader distribution, the middle band highlights the typical range, and the markers help separate the median from the average.